FORESIGHT INVESTMENTS PCC LIMITED - Foresight Group
FORESIGHT INVESTMENTS PCC LIMITED - Foresight Group
FORESIGHT INVESTMENTS PCC LIMITED - Foresight Group
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>FORESIGHT</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
A PROTECTED CELL INVESTMENT COMPANY REGISTERED wITH <strong>LIMITED</strong><br />
LIAbILITY IN GUERNSEY wITH REGISTRATION NUMbER 53301<br />
<strong>FORESIGHT</strong> ENVIRONMENTAL CELL<br />
CELL PARTICULARS AND APPLICATION FORM<br />
MAY 2011
IMPORTANT NOTICE<br />
If you are in any doubt about the contents of this document<br />
you should consult your stockbroker, bank manager, solicitor,<br />
accountant, legal or professional adviser or other financial adviser.<br />
The directors of the Company have taken all reasonable care<br />
to ensure that the facts stated in this document are true and<br />
accurate in all material respects, and that there are no other facts<br />
the omission of which would make misleading any statement in<br />
this document, whether of facts or of opinion. All the directors<br />
accept responsibility accordingly.<br />
No broker, dealer or other person has been authorised by the<br />
Company or by any of its agents to issue any advertisement or to<br />
give any information or to make any representations in connection<br />
with the offering or sale of Participating Shares other than those<br />
contained in these Cell Particulars and, if issued, given or made,<br />
such advertisement, information or representations must not be<br />
relied upon as having been authorised by the Company or any of<br />
its agents. Statements made in these Cell Particulars are based on<br />
the law and practice in force at the date hereof and are subject to<br />
changes therein. Neither the delivery of these Cell Particulars nor<br />
the issue of Participating Shares shall, under any circumstances,<br />
imply that there has been no change in the circumstances<br />
affecting any of the matters contained in these Cell Particulars<br />
since the date of these Cell Particulars.<br />
These Cell Particulars do not constitute, and may not be used<br />
for the purposes of, an offer or solicitation to anyone in any<br />
jurisdiction in which such offer or solicitation is not authorised<br />
or to any person to whom it is unlawful to make such offer or<br />
solicitation. The distribution of these Cell Particulars and the<br />
offering of Participating Shares in certain jurisdictions may be<br />
restricted and accordingly persons into whose possession such<br />
documents come are required to inform themselves about and to<br />
observe such restrictions.<br />
None of the Participating Shares has been or will be registered<br />
under the 1933 Act, and, except as described herein, none of the<br />
Participating Shares may be offered or sold, directly or indirectly,<br />
in the United States of America, its territories or possessions or<br />
any area subject to its jurisdiction including the Commonwealth<br />
of Puerto Rico (the ‘United States’) or to any resident thereof<br />
(including any corporation, partnership or other entity created or<br />
organised in or under the laws of the United States or any political<br />
subdivision thereof) or any estate or trust that is subject to United<br />
States federal income taxation regardless of the source of its<br />
income. In addition, the Company and the Cell have not been and<br />
will not be registered under the 1940 Act and neither the Fund<br />
Manager nor the Investment Manager has been registered under<br />
the 1940 Act.<br />
The Company is a registered closed-ended investment scheme<br />
registered pursuant to the Protection of Investors (bailiwick of<br />
Guernsey) Law, 1987, as amended and the Registered Collective<br />
Investment Scheme Rules 2008 issued by the Guernsey Financial<br />
Services Commission (the “Commission”). The Commission, in<br />
granting registration, has not reviewed this document but has<br />
relied upon specific warranties provided by JTC Fund Services<br />
(Guernsey) Limited, the Company’s designated manager. Neither<br />
the Guernsey Financial Services Commission nor the States of<br />
Guernsey Policy Council take any responsibility for the financial<br />
soundness of the Company or for the correctness of any of the<br />
statements made or opinions expressed with regard to it. It should<br />
be remembered that the price of securities and the income (as<br />
appropriate) from them can go down as well as up.<br />
A registered collective investment scheme is not permitted to be<br />
directly offered to the public in Guernsey but may be offered to<br />
regulated entities in Guernsey or offered to the public by entities<br />
appropriately licensed under the Protection of Investors (bailiwick<br />
of Guernsey) Law, 1987, as amended.<br />
The Company does not constitute a “collective investment<br />
scheme” for the purposes of UK law and can therefore be<br />
promoted in the UK in accordance with section 21 of the Financial<br />
Services and Markets Act 2000 (“FSMA”). The content of this<br />
document has been approved by <strong>Foresight</strong> <strong>Group</strong> LLP, an<br />
authorised person within the meaning of FSMA for the purposes<br />
of section 21 of FSMA, and this document and the Scheme<br />
Particulars constitute a financial promotion. The rules for the<br />
protection of retail clients made under the Financial Services<br />
and Markets Act 2000 (“FSMA”) do not apply to investors in the<br />
Company and compensation under the UK Investor Compensation<br />
Scheme will not be available. This document does not constitute<br />
a prospectus as defined in the Prospectus Regulations 2005 (the<br />
“Regulations”) and has not been prepared in accordance with the<br />
requirements of the Regulations.<br />
The Directors intend to apply for the Participating Shares to be<br />
listed on the Official List of the Channel Islands Stock Exchange. In<br />
any event, there is no active secondary market in the Participating<br />
Shares and the Directors do not anticipate that such a market<br />
will develop. Neither the admission of the Participating Shares<br />
(if it occurs) to the Official List of the Channel Islands Stock<br />
Exchange nor the approval of these Cell Particulars pursuant to<br />
the listing requirements of the Channel Islands Stock Exchange<br />
will constitute a warranty or representation by the Channel Islands<br />
Stock Exchange as to the competence of the service providers to,<br />
or any other party connected with, the Company, the adequacy<br />
of information contained in these Cell Particulars or the suitability<br />
of the Company for investment purposes. where a listing<br />
application is made, these Cell Particulars, as may be modified,<br />
and any related supplemental Cell Particulars will constitute the<br />
listing document for the Company and include particulars given<br />
in compliance with the listing rules of the Channel Islands Stock<br />
Exchange for the purpose of giving information with regard to the<br />
Company.<br />
An investment in any Cell of the Company should be regarded as<br />
a long-term investment. The value of Participating Shares may<br />
fall as well as rise. There can be no guarantee that the investment<br />
objective of the Cell will be achieved and investors may not get<br />
back the amount originally invested. Investors are referred to the<br />
section headed “RISK FACTORS” in the Scheme Particulars.<br />
Distribution of the Scheme Particulars which accompany these<br />
Cell Particulars is not authorised in any jurisdiction after the<br />
date of publication of the Company’s first report and financial<br />
statements unless they are accompanied by the Company’s most<br />
recent annual report and financial statements or, if more recent,<br />
its interim report and financial statements.<br />
Prospective investors should not treat the contents of these<br />
Cell Particulars as advice relating to legal, taxation, investment,<br />
exchange control or any other matters and are recommended<br />
to consult their own professional advisers concerning the<br />
consequences of their acquiring, holding or disposing of<br />
Participating Shares.
CONTENTS<br />
PART I - <strong>FORESIGHT</strong> ENVIRONMENTAL CELL 4<br />
Introduction 4<br />
<strong>Foresight</strong> Environmental Fund LP 4<br />
Investment policy 6<br />
Distributions 6<br />
Listing 6<br />
Transfer of Participating Shares 6<br />
Subscriptions under the First Offer 6<br />
Subscriptions under the Second Offer 6<br />
Minimum aggregate subscription and allotment and issue of Participating Shares 7<br />
Classes of Participating Shares 7<br />
Borrowing 7<br />
Conflicts of interest 7<br />
Investment Manager 7<br />
Investment Advisor 7<br />
Administrator 7<br />
Calculation of Net Asset Value 7<br />
Reports and financial statements 7<br />
Register 8<br />
Fees and expenses applicable to the Cell 8<br />
Initial commission 8<br />
Additional Participating Shares 8<br />
Trail commission 8<br />
Fees and expenses of <strong>Foresight</strong> Environmental Fund LP 9<br />
PART II – <strong>FORESIGHT</strong> ENVIRONMENTAL FUND LP 10<br />
PART III – TAXATION 20<br />
PART IV – RISK FACTORS 22<br />
PART V – DEFINITIONS 26<br />
APPLICATION FORM 30<br />
These Cell Particulars should be read and construed in conjunction with the Scheme Particulars. This document is deemed to<br />
be incorporated in and to form part of the Scheme Particulars and may not be distributed unless it is accompanied by them<br />
and any other documentation as the Scheme Particulars may prescribe.<br />
The Directors accept responsibility for the information contained in these Cell Particulars. To the best of the knowledge and<br />
belief of the Directors (who have taken all reasonable care to ensure that such is the case) the information contained in these<br />
Cell Particulars is in accordance with the facts and does not omit anything likely to affect the import of such information.<br />
Page
04<br />
PART I - <strong>FORESIGHT</strong> ENVIRONMENTAL CELL<br />
INTRODuCTION<br />
<strong>Foresight</strong> Environmental Cell (the “Cell”)<br />
is a cell of <strong>Foresight</strong> Investments <strong>PCC</strong><br />
Limited (the “Company”), a closed-ended<br />
protected cell investment company<br />
registered with limited liability in Guernsey<br />
on 4 April 2011 and authorised by the<br />
Guernsey Financial Services Commission<br />
as a registered closed-ended fund.<br />
The investment objective of the Cell<br />
is to provide investors with access to<br />
<strong>Foresight</strong> Environmental Fund LP (the<br />
“Fund”), an English limited partnership<br />
managed by <strong>Foresight</strong> <strong>Group</strong> LLP (the<br />
“Fund Manager”). The Fund is primarily<br />
for institutional investors and would not<br />
normally be readily accessible to private<br />
investors. The Cell has been established to<br />
allow private investors to participate in the<br />
Fund alongside major institutions such as<br />
the European Investment bank, which has<br />
already committed £35 million to the Fund<br />
on behalf of the London Green Fund.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
<strong>FORESIGHT</strong> ENVIRONMENTAL FUND LP<br />
Market shift creates demand for investment<br />
The UK waste sector is in a phase of transformation, as<br />
recycling and renewable energy generation displace the<br />
traditional dependence on landfill. <strong>Foresight</strong> believes<br />
that the rapidly rising cost of landfill and the premium<br />
value of renewable energy is likely to support exciting<br />
returns on investment in new waste-fuelled power stations<br />
and recycling infrastructure. The Fund seeks to exploit<br />
this opportunity by providing development capital to<br />
companies that are positioned to lead the market and<br />
which, in <strong>Foresight</strong>’s opinion, are likely to command<br />
premium valuations as the market consolidates.<br />
The Fund will focus its investment in Greater London,<br />
where demand for investment is particularly strong.<br />
London recycles less of its municipal waste than any other<br />
English region and there is strong political support for the<br />
roll-out of new waste infrastructure. The cancellation in<br />
2010 of PFI credits worth £1.5 billion is expected to boost<br />
demand for alternative forms of finance, which the Fund is<br />
well positioned to meet.<br />
Investment strategy focused on value creation<br />
The Fund will invest in companies leading the growth of<br />
local-scale recycling and renewable energy generation<br />
from waste. Target companies will have access to proven<br />
technology, consented sites and reliable waste streams,<br />
helping them to build facilities on time and on budget and<br />
to deliver long-term sustainable cashflows.<br />
The Fund intends to position its investee companies as<br />
attractive acquisition targets for major players in waste<br />
management and energy generation, with the objective<br />
of achieving premium value through trade sales after 3-5<br />
years. The Fund objective is a 20%-30% compound annual<br />
net return to investors. Cell Investors should note that<br />
forecasts are not reliable indicators of future performance<br />
and there is no guarantee that such targets or projections<br />
will be achieved.
Demonstrable pipeline of potential investments<br />
<strong>Foresight</strong>’s total investment pipeline at the start of 2011<br />
represented an aggregate investment opportunity of<br />
£500 million. It includes opportunities in each of four key<br />
market segments:<br />
n Food waste for energy and agriculture<br />
n waste plastics for food-packaging and construction<br />
n wood waste for energy and animal bedding<br />
n Residual waste sorting and energy generation<br />
<strong>Foresight</strong> has direct relationships with key management<br />
and sponsor partners of 9 potential investees, representing<br />
£200 million of the aggregate investment pipeline.<br />
<strong>Foresight</strong> believes that these relationships should provide<br />
strong early momentum in the delivery of the Fund’s<br />
investment programme.<br />
An experienced and reliable manager<br />
<strong>Foresight</strong> has been investing in unquoted opportunities<br />
for more than 20 years and has a track record of creating<br />
shareholder value through active management. The firm has<br />
funds under management of over £200 million and delivered<br />
a net return to investors of 4 times total commitments in its<br />
first institutional fund.<br />
<strong>Foresight</strong>’s investment team combines senior-level experience<br />
in operational management with proven expertise in structuring<br />
and managing unquoted investments. Team members have been<br />
directly involved in financing, building and managing comparable<br />
processing facilities in the chemicals and waste sectors, and<br />
managing more than 60 unquoted investments. <strong>Foresight</strong> will<br />
work intensively with the executive management team of each<br />
investee company in order to drive value creation, control risk and<br />
deliver profitable exits.<br />
Aligned with sustainability principles<br />
The Fund will seek to support businesses that are sustainable,<br />
both from an economic and an environmental viewpoint.<br />
Environmental sustainability is important not only for ethical<br />
reasons, but also because it appears likely that legislators at the<br />
EU and national levels will continue to pursue the environmental<br />
agenda, with the result that business models which do not<br />
meet sustainability criteria may be subject to increasing costs<br />
or regulatory hurdles. The Fund is aligned with sustainable<br />
investing principles, particularly in the areas of energy supply<br />
security, replacement of fossil fuels with renewable energy<br />
and diversion of waste from landfill to more valuable uses. The<br />
Fund’s investment programme will also create local employment,<br />
and will be managed with proper consideration of other<br />
sustainability indicators such as emissions and the quality of the<br />
local environment. <strong>Foresight</strong> believes that its focus on localscale<br />
facilities positions the Fund as an attractive opportunity<br />
for investors interested in promoting more environmentally<br />
sustainable use of resources.<br />
For further details of <strong>Foresight</strong> Environmental Fund LP, see Part II<br />
commencing on page 8.<br />
There is no intention to materially change the investment<br />
objectives of the Cell other than in exceptional circumstances<br />
and in any event not without the approval of a majority of<br />
Cell Investors.<br />
THE ObJECTIVE OF THE FUND IS TO REALISE SIGNIFICANT CAPITAL GAINS bY<br />
EXPLOITING THE TRANSFORMATION OF THE wASTE INDUSTRY AwAY FROM<br />
LANDFILL AND TOwARDS RECYCLING AND ENERGY GENERATION.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 05
06<br />
PART I - <strong>FORESIGHT</strong> ENVIRONMENTAL CELL<br />
INVESTMENT POLICY<br />
The Cell will commit substantially all of its capital (net of fees<br />
and expenses) to the Fund and will become a limited partner in<br />
the Fund. Any assets of the Cell not invested in the Fund or used<br />
to pay fees and expenses, and any monies raised by the Cell that<br />
are yet to be drawn down by the Fund, will be invested in cash or<br />
near-cash investments.<br />
The Fund has been established to invest in unquoted<br />
companies engaged in the development, construction and<br />
operation of facilities for the treatment or recycling of waste,<br />
the manufacture of products from recycled materials, and<br />
the generation of renewable energy from waste, focusing on<br />
investment to support construction of such facilities in Greater<br />
London. The market opportunity and investment rationale are<br />
more fully explained in Part II of this document.<br />
DISTRIbUTIONS<br />
The Cell will distribute net income, gains and capital by<br />
means of dividends, share redemptions or otherwise as<br />
the Directors may determine, subject in each case to<br />
retention of sufficient funds to meet the Cell’s obligations<br />
to the Fund and to pay foreseeable costs and liabilities.<br />
where the Participating Shares are listed on the CISX, any<br />
dividend declared on the Participating Shares will be paid<br />
in compliance with any applicable laws and Channel Islands<br />
Stock Exchange requirements.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
LISTING<br />
It is the intention of the Directors to seek a listing for<br />
the Participating Shares on the Channel Islands Stock<br />
Exchange (“CISX”) as soon as practicable. There is no<br />
guarantee that such a listing will occur. There is no<br />
active secondary market in the Participating Shares and<br />
notwithstanding any listing the Directors do not anticipate<br />
that such a market is likely to develop.<br />
TRANSFER OF PARTICIPATING SHARES<br />
The Participating Shares are freely transferable, although<br />
the Directors have discretion to refuse to register a<br />
transfer of Participating Shares in certain circumstances<br />
under the provisions of the Articles. The Directors will not<br />
exercise such discretion unreasonably.<br />
based on interpretations of the 1940 Act by the staff of<br />
the United States Securities and Exchange Commission<br />
relating to foreign investment entities, if the Company has<br />
more than 100 beneficial owners of its Participating Shares<br />
who are US Persons, it may become subject to the 1940<br />
Act. The Company will not be registered under the 1940<br />
Act and the Directors will not knowingly permit US Persons<br />
to be shareholders.<br />
ThIS DOCuMENT SETS OuT TwO OFFERS, ThE FIRST OFFER AND ThE SECOND OFFER. ThE OFFER<br />
PRICE AND ThE CLOSINg DATE IS ThE SAME FOR BOTh OFFERS. ThE SIgNIFICANT DIFFERENCE<br />
BETwEEN ThE TwO OFFERS IS ThE MINIMuM SuBSCRIPTION AMOuNT, AS DESCRIBED BELOw.<br />
SUbSCRIPTIONS UNDER THE FIRST OFFER<br />
During the First Offer Application Period up to 2,176,000 Participating Shares will be offered at £1.00 per<br />
Participating Share. Investors may apply for any whole number of Participating Shares under the First Offer,<br />
subject to the minimum subscription of £10,000. All subscriptions over £43,500 will be deemed to be made under<br />
the Second Offer.<br />
SUbSCRIPTIONS UNDER THE SECOND OFFER<br />
During the Second Offer Application Period an unlimited number of Participating Shares will be offered at £1.00<br />
per Participating Share. Investors may apply for any whole number of Participating Shares under the Second Offer,<br />
subject to the minimum subscription of £43,500. The minimum subscription is reduced to £10,000 if:<br />
n the application is made by one of up to 99 persons to whom the Second Offer was specifically made or directed<br />
by <strong>Foresight</strong> with a statement to that effect clearly affixed to the Application Form; or<br />
n the application is made by a Qualified Investor on its own behalf or on behalf of a person who has engaged the<br />
Qualified Investor to act as his agent on terms which enable the Qualified Investor to make decisions concerning<br />
the acceptance of offers of transferable securities on that person’s behalf without reference to that person.
MINIMUM AGGREGATE SUbSCRIPTION<br />
AND ALLOTMENT AND ISSUE OF<br />
PARTICIPATING SHARES<br />
The Directors will not issue any Participating Shares until<br />
applications for Participating Shares totalling £1 million in<br />
aggregate have been received under the Offers. If applications<br />
for Participating Shares to this value are not received, the<br />
Cell may not proceed and in such case subscription monies<br />
received will be returned to investors without interest<br />
(which will instead be applied to meet the costs of the<br />
Company incurred in relation to the anticipated fund-raising<br />
at that point).<br />
The Directors reserve the right to reject any application in<br />
whole or part or to scale down any application. The Directors<br />
also reserve the right to allocate applications between the First<br />
Offer and the Second Offer as they see fit.<br />
Participating Shares will be allotted and issued on the last<br />
business Day of the First Offer Application Period or the<br />
Second Offer Application Period (as relevant) or otherwise<br />
at the discretion of the Directors. Any interest earned on<br />
application monies held by the Company pending allotment of<br />
Participating Shares will be added to the assets of the Cell.<br />
A contract note will be sent by post to each Cell Investor,<br />
providing details of the allotment of Participating Shares,<br />
within 14 days of that allotment.<br />
CLASSES OF PARTICIPATING SHARES<br />
It is intended that there will be one class of<br />
Participating Share.<br />
bORROwING<br />
The Directors may exercise the powers of the Company relating<br />
to the Cell to borrow, but they intend to restrict the borrowing<br />
of the Cell so as to ensure that no sum will be borrowed other<br />
than for working capital purposes. borrowing will not be used<br />
by the Cell to generate leverage, nor will the Cell engage in<br />
derivative transactions or other transactions with a similar<br />
effect. borrowing transactions will only be carried out on the<br />
basis that recourse may only be had against the assets of the<br />
Cell. The Cell will not participate in any hedging activities.<br />
CONFLICTS OF INTEREST<br />
The Investment Manager or its affiliates may provide<br />
investment advisory and management services to other<br />
clients in addition to the Cell. The Directors and the Investment<br />
Manager will endeavour to ensure that any conflict which does<br />
arise is resolved fairly.<br />
Further details of potential conflicts of interest are<br />
set out in the “Risk Factors” section, as well as in the<br />
Scheme Particulars.<br />
INVESTMENT MANAGER<br />
The Company has appointed <strong>Foresight</strong> <strong>Group</strong> CI Limited to act<br />
as Investment Manager to the Cell. The Investment Manager<br />
will manage the assets of the Cell with a view to achieving its<br />
investment objectives.<br />
INVESTMENT ADVISOR<br />
The Investment Manager has appointed <strong>Foresight</strong> <strong>Group</strong> LLP<br />
to act as Investment Advisor to the Investment Manager. The<br />
Investment Advisor provides investment advice and has no<br />
discretionary powers.<br />
ADMINISTRATOR<br />
JTC Fund Services (Guernsey) Limited has been appointed as<br />
Administrator of the Cell.<br />
CALCULATION OF NET ASSET VALUE<br />
The Administrator will calculate the Net Asset Value using<br />
valuations provided by the Fund Manager. Valuations will<br />
normally be updated on a six-monthly basis.<br />
where Participating Shares are listed on the CISX, the updated<br />
Net Asset Value of the Cell and of each Participating Share will<br />
be notified immediately by the Administrator to the CISX and<br />
the Administrator will give CISX notice of any suspension of<br />
valuation without delay and all reasonable steps will be taken<br />
to bring such a suspension to an end as quickly<br />
as possible.<br />
REPORTS AND FINANCIAL STATEMENTS<br />
An annual report, including the Net Asset Value per<br />
Participating Share and the audited financial statements of<br />
the Cell, will be sent to Cell Investors and, where Participating<br />
Shares are listed on the CISX, to the CISX, at least 21 days<br />
before the annual general meeting and in any event within six<br />
months of the financial year end, whichever is the earlier.<br />
A half-yearly report, including the Net Asset Value per<br />
Participating Share and the unaudited accounts of the Cell,<br />
will be sent to Cell Investors and (where Participating Shares<br />
are listed on the CISX) to the CISX within four months of the<br />
end of the relevant period.<br />
The first interim accounts will be for the period ending 31 March<br />
2012 and the first audited financial statements will<br />
be for the period ending 30 September 2012. Accounts<br />
will be reported in UK GAAP unless otherwise decided by<br />
the Directors.<br />
Annual and half-yearly reports and the latest Net Asset Value<br />
will be published at www.foresightgroup.eu or any other such<br />
website as may be maintained or nominated by the Investment<br />
Manager from time to time. Reports will be sent to Cell<br />
Investors in electronic form unless otherwise requested.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 07
08<br />
PART I - <strong>FORESIGHT</strong> ENVIRONMENTAL CELL<br />
REGISTER<br />
All Participating Shares will be issued in registered form and<br />
the register will be conclusive evidence of ownership. The<br />
register may be inspected at the office of the Administrator<br />
during usual office hours. Any change to a Cell Investor’s<br />
personal details must be notified immediately to the<br />
Administrator in writing.<br />
FEES AND EXPENSES APPLICAbLE TO<br />
THE CELL<br />
The Investment Manager will not receive a management<br />
fee from the Cell or from the Company. The Investment<br />
Manager will be remunerated by the Fund Manager and<br />
its Associates.<br />
The Cell will pay <strong>Foresight</strong> an initial charge equal to<br />
5.5% of the total amount subscribed for Participating<br />
Shares (the “Initial Charge”) and an amount in respect<br />
of trail commission as described below. <strong>Foresight</strong> will be<br />
responsible for all costs and expenses associated with the<br />
offering of Participating Shares, including costs incurred in<br />
connection with the preparation of these Cell Particulars,<br />
regulatory submissions, registration fees, document duty,<br />
professional fees and expenses, initial commission and<br />
trail commission.<br />
The Cell is responsible for<br />
(i) operational costs incurred in connection with running<br />
the Cell, including the Administrator’s fee of £12,000<br />
per annum (subject to annual review) and the<br />
Administrator’s reasonable out of pocket expenses<br />
incurred in the administration of the Cell;<br />
(ii) any Interest Charge payable to the Fund;<br />
(iii) any CISX initial and annual listing fees;<br />
(iv) any other operating costs or other liabilities of the<br />
Company which are, in the opinion of the Directors,<br />
attributable to the Cell; and<br />
(v) the Cell’s pro rata share of the general operating costs<br />
and liabilities of the Company (as further described in<br />
the section of the Scheme Particulars headed “Other<br />
Operating Expenses”) based on the Net Asset Value<br />
of the Cell as a percentage of the Net Asset Value of<br />
the Company;<br />
If the expenses detailed at (i) to (v) above exceed 1%<br />
per annum of total subscriptions over the life of the Cell,<br />
the Investment Manager will be liable to pay such excess to<br />
the Cell.<br />
The fees of the Investment Advisor will be borne by the<br />
Investment Manager.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
INITIAL COMMISSION<br />
Authorised financial intermediaries who, acting on behalf<br />
of their clients, return valid Application Forms bearing their<br />
stamp and FSA number will normally be paid commission (the<br />
“Initial Commission”) at 3% on the amount subscribed for the<br />
Participating Shares allocated for each such Application Form.<br />
The Initial Commission will be paid by <strong>Foresight</strong> out of the<br />
Initial Charge.<br />
ADDITIONAL PARTICIPATING SHARES<br />
Financial intermediaries may agree to waive Initial Commission<br />
in respect of an application. where Initial Commission is<br />
waived, the relevant Cell Investor will be allotted a total number<br />
of Participating Shares equal to: (i) those applied for plus<br />
(ii) a number of additional Participating Shares equal to the<br />
amount of Initial Commission waived divided by £1. Additional<br />
Participating Shares will not themselves be subject to payment<br />
of Initial Commission.<br />
TRAIL COMMISSION<br />
Authorised financial intermediaries who, acting on behalf of<br />
their clients, return valid Application Forms bearing their stamp<br />
and FSA number, will be paid an annual trail commission of<br />
0.5% of the net asset base value of their clients’ Participating<br />
Shares, provided they continue to act for the client and the<br />
client continues to hold such Participating Shares. For this<br />
purpose, “net asset base value” means the Net Asset Value<br />
per Participating Share as shown in the audited financial<br />
statements of the Cell as at the end of the preceding financial<br />
year (and, until audited financial statements are first published,<br />
“net asset base value” means 94.5p). The annual trail<br />
commission will be charged as a fee payable by the Cell to the<br />
Investment Manager, and the Investment Manager will settle<br />
such commissions with relevant intermediaries through its<br />
associate, <strong>Foresight</strong> Fund Managers Limited.<br />
It is expected that annual trail commission will be paid one<br />
month after publication of the annual report of the Company in<br />
each year. The Cell will be entitled to rely on a notification from<br />
a Cell Investor that it has changed its adviser, in which case the<br />
trail commission will cease to be payable to the original adviser<br />
and will be payable to the new adviser if one is appointed.<br />
No payment of trail commission will be made to the extent<br />
that the cumulative trail commission would exceed 3% of the<br />
subscription price of the relevant Participating Shares or in<br />
respect of any period commencing after the sixth anniversary<br />
of the closing date of the First Offer or of the Second Offer<br />
(whichever is later). Financial intermediaries should keep a<br />
record of Application Forms submitted bearing their stamp to<br />
substantiate any claim for commission.
FEES AND EXPENSES OF <strong>FORESIGHT</strong><br />
ENVIRONMENTAL FUND LP<br />
The Cell will be a limited partner in the Fund and as such will<br />
bear its share of the fees and expenses of the Fund. The Fund<br />
will pay to the Fund Manager a management fee of 2% of<br />
Total Commitments during the Investment Period, reducing<br />
thereafter to 2% of Total Commitments less the acquisition<br />
cost of Investments fully distributed or written off. This<br />
management fee will be reduced by 80% of the value (net of<br />
tax) of any fees received and retained by the Fund Manager<br />
and its Associates that are agreed upon at the time of and<br />
directly referable to the making of an Investment by the Fund.<br />
The Fund Manager is entitled to a performance incentive of<br />
20% of net profits, which is only payable after the Cell has<br />
achieved a compound annual return of 8% on its investment<br />
in the Fund.<br />
The Fund will pay its own establishment costs and operating<br />
expenses such as legal, audit, printing, administration, banking,<br />
custody, taxation and other running costs of the Fund, and<br />
third-party costs associated with uncompleted transactions.<br />
The Fund Manager and its Associates will bear their own<br />
administrative costs and overhead expenses of managing the<br />
Fund and originating and monitoring Investments and will not<br />
be entitled to recover these from the Fund.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 09
10<br />
PART II - <strong>FORESIGHT</strong> ENVIRONMENTAL FUND LP<br />
MARKET OPPORTUNITY<br />
<strong>Foresight</strong> has identified four key market segments which offer attractive opportunities for<br />
investment. The opportunity in each segment is described below.<br />
Sector 1: Food waste for energy and agriculture<br />
London produces 2.6 million tonnes of organic waste<br />
annually, which if processed by a mix of anaerobic digestion<br />
and in-vessel composting could, in <strong>Foresight</strong>’s view,<br />
generate revenues of around £150 million each year on a<br />
capital investment of around £280 million. In 2008/9 less<br />
than 1% of London’s municipal solid waste was treated<br />
using anaerobic digestion, and only 25% was recycled<br />
or composted. <strong>Foresight</strong> believes that both anaerobic<br />
digestion and advanced thermal aerobic digestion have a<br />
role to play in improving this performance. The investment<br />
pipeline includes companies involved in both anaerobic<br />
digestion and fertilizer production through advanced<br />
thermal aerobic digestion.<br />
Segregated collection of food waste has begun in ten<br />
boroughs, and a further seven collect food and green<br />
waste together. To achieve the targets set by the<br />
Mayor’s Draft waste Management Strategy of 60%<br />
recycling or composting, source segregated collections<br />
will have to be significantly increased. The commercial and<br />
retail sector has also started to separate food waste, but<br />
with few facilities capable of handling this material in the<br />
Greater London area, change is needed to reduce waste<br />
road miles. There is thus a clear and growing demand for<br />
new facilities capable of maximizing the value of London’s<br />
waste food resource.<br />
Sector 2: Plastics for food-packaging<br />
and construction<br />
An estimated 278,000 tonnes of plastic enters the London<br />
municipal waste stream each year, most of which has<br />
traditionally been sent to landfill. Many forms of plastic are<br />
of high-value and are readily recyclable, and <strong>Foresight</strong> has<br />
direct experience of successful economic approaches to the<br />
sector through companies such as Closed Loop Recycling,<br />
2K Manufacturing and i-Plas. Through wider adoption<br />
of these approaches, <strong>Foresight</strong> estimates that annual<br />
revenues of over £200 million could be generated on<br />
capital investment of around £380 million. There has been<br />
significant progress on capturing plastics from municipal<br />
waste, with all the London boroughs providing kerbside<br />
collection for plastics, along with other dry recyclables<br />
such as paper and mixed cans. As household participation<br />
rates increase and collections from retail and commercial<br />
properties gain momentum, there is a need for new<br />
capacity to refine or re-mould plastics in London.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
Sector 3: wood waste for biomass fuel and<br />
animal bedding<br />
Approximately 800,000 tonnes of wood waste enters the<br />
London waste stream each year, much of which is currently<br />
sent to landfill or exported. <strong>Foresight</strong> believes that the<br />
clean fraction of this waste can be cost–effectively refined<br />
and pelletised for use as animal bedding or biomass fuel.<br />
The remainder should be used to generate renewable<br />
heat and electricity directly through gasification or other<br />
technologies. <strong>Foresight</strong> estimates that managing London’s<br />
wood waste by this combination of processes could create<br />
annual revenues of over £70 million at a capital cost of<br />
around £240 million.<br />
From its direct experience of both recycling waste wood<br />
and generating energy from it, <strong>Foresight</strong> believes that<br />
a differentiated, local-scale approach to waste wood is<br />
important. Sorting and pelletising can capture more value<br />
from the clean fractions of this waste stream than thermal<br />
treatment. For the lower-grade fractions, thermal facilities<br />
sized to local power needs are more acceptable to local<br />
populations and minimize transport impacts.<br />
Sector 4: Residual waste sorting and<br />
energy generation<br />
Residual waste arising in London totals approximately 1.9<br />
million tonnes annually, excluding wastes such as food,<br />
wood and plastic bottles and the present tonnage of<br />
municipal waste being used in waste–to–energy plants.<br />
<strong>Foresight</strong> estimates that annual revenues of over £110<br />
million could be created by investment of around £270<br />
million in a combination of facilities to sort the waste for<br />
further re-processing, to produce solid recovered fuel and<br />
to generate energy directly in combined heat and power<br />
plants. Residual waste is potentially a rich source of biomass<br />
as a sustainable local fuel source. The key is investment in<br />
the right level of refining technology to make this biomass<br />
suitable for dedicated biomass power plants. In addition<br />
there continues to be a requirement for further processing<br />
capacity for a wider range of recyclable materials, such<br />
as plastics and textiles, as well as the more common cans,<br />
paper and glass.
INVESTMENT SELECTION<br />
Deal origination<br />
<strong>Foresight</strong> originates investment opportunities by engaging<br />
directly with entrepreneurs, owners of waste feedstocks, potential<br />
customers for power and recycled materials, and a network of<br />
other contacts. <strong>Foresight</strong> believes that its relationships with these<br />
individuals and organisations can provide privileged access to<br />
investment opportunities. They can also provide contacts and<br />
insight to enable <strong>Foresight</strong> to more swiftly and accurately assess<br />
the quality of each investment opportunity and deliver project<br />
execution whilst minimising risk.<br />
The Fund will provide development capital to support the<br />
construction and operation of recycling and energy from waste<br />
facilities in Greater London. Selection of investments for the<br />
Fund will be based on assessment against the key parameters<br />
shown below:<br />
Highest value for materials<br />
Facilities should seek to maximise the embedded value of<br />
materials through recycling. In energy generation, projects using<br />
combined heat and power can maximise the energy value of<br />
waste materials. burning of unsorted waste is not consistent with<br />
achieving maximum value and will not be supported by the Fund.<br />
Facilities will by preference serve large or growing markets,<br />
where demand for recycled materials or renewable energy is<br />
unmet. Recycled plastic for food-grade packaging is an example<br />
of such a market, where <strong>Foresight</strong> has direct operational and<br />
investment experience.<br />
Sustainability<br />
Environmental sustainability is a key driver of long-term economic<br />
value and therefore of returns. Facilities must contribute to the<br />
reduction of CO 2 emissions, diversion of waste from landfill and<br />
creation of local employment.<br />
Feedstock security<br />
waste infrastructure projects can be attractive investments<br />
without the benefit of municipal contracts, provided an effective<br />
private sector contracting strategy is in place. <strong>Foresight</strong> has<br />
negotiated directly with waste managers and believes that joint<br />
venturing with established waste management organisations to<br />
support merchant facilities is a viable alternative to seeking longterm<br />
municipal contracts.<br />
<strong>INVESTMENTS</strong> SELECTED FOR THE FUND wILL HAVE THE POTENTIAL<br />
TO DELIVER COMPOUND ANNUAL RETURNS OF OVER 20%.<br />
Sized to local needs<br />
The Fund will prioritise projects whose capacity matches local<br />
waste arisings, typically treating 20,000-100,000 tonnes<br />
annually. At this scale, projects are more acceptable to local<br />
communities, benefit from low transport costs and can achieve<br />
feedstock security by becoming embedded within the local<br />
waste management network. Viable options for using heat are<br />
also more readily available at this local scale, increasing the<br />
potential for a more decentralized energy system.<br />
Reliable, advanced technology<br />
The Fund will prioritise investment in facilities using advanced<br />
technology that is commercially proven. The Fund may also<br />
support projects where advanced technologies still need tuning<br />
to UK-specific waste characteristics. <strong>Foresight</strong> has hands-on<br />
experience of advanced technologies including gasification,<br />
and has access to a network of consultants and contractors<br />
qualified to advise on specific processes.<br />
Ready for construction<br />
In order to avoid planning risk, the Fund will invest primarily to<br />
support projects for which planning consent has been granted<br />
and which, with the support of the Fund’s participation, are<br />
certain to reach financial close. Projects in the development<br />
phase may also be considered in some cases.<br />
Credible counterparties<br />
Projects will typically involve key partners for waste supply,<br />
process engineering and product offtake, whose reputation<br />
and financial standing can influence success. The capability<br />
and commitment of executive management and co-investors<br />
may also affect outcomes. with long experience in the waste<br />
industry and in private equity, <strong>Foresight</strong>’s team is well-equipped<br />
to assess these parties and to build successful relationships.<br />
Value creation opportunity<br />
Each investment must offer financial returns consistent with<br />
the overall Fund objectives. Returns are driven not only by<br />
project success, but also by the terms on which the Fund<br />
invests and, at the appropriate time, realises its investment.<br />
A robust exit strategy is therefore a vital part of the investment<br />
decision. Having realised more than 50 investments over 25<br />
years, <strong>Foresight</strong> is well placed to assess and deliver exits that<br />
maximise value for the Fund.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 11
12<br />
PART II - <strong>FORESIGHT</strong> ENVIRONMENTAL FUND LLP<br />
FUND MANAGER<br />
Background<br />
<strong>Foresight</strong> <strong>Group</strong> LLP (the “Fund Manager”) is a UK limited<br />
liability partnership owned by its investment partners.<br />
Founded in 1984, the firm has successfully invested<br />
in unquoted companies in the UK, continental Europe<br />
and the United States and has realised more than 50<br />
investments, achieving an average multiple of 4.7 times<br />
investment cost. It currently manages over £300 million.<br />
<strong>Foresight</strong> began investing in the target sectors in 2007<br />
and has invested over £60 million in 10 companies. This<br />
experience has enabled <strong>Foresight</strong> to build its profile as<br />
a leading investor and credible financing partner for<br />
entrepreneurs and companies in this market. It has also<br />
allowed the firm to create a team with a unique range<br />
of investment and operational management skills and<br />
experience.<br />
<strong>Foresight</strong> has 34 staff based in offices in the UK, Italy and<br />
Spain, including 19 investment professionals across three<br />
teams. <strong>Foresight</strong>’s other investment focus areas are solar<br />
power projects, smaller buyouts in the UK and secondary<br />
portfolio management.<br />
<strong>Foresight</strong>’s finance and investor support teams<br />
have the experience and resources to provide a high<br />
quality of service to investors in the Fund. Eleven<br />
staff are responsible for fund administration, investor<br />
communications, compliance and financial management.<br />
Their experience includes administration of complex<br />
listed funds and communicating with a wide base<br />
of investors.<br />
Track record<br />
<strong>Foresight</strong> has demonstrated the ability to select and<br />
negotiate attractive investments in unquoted growth<br />
companies, and to realise value for investors. The firm’s<br />
first institutional fund raised £20 million, made 28<br />
investments and returned £80 million to investors.<br />
The average holding period for investments was around<br />
five years.<br />
<strong>Foresight</strong>’s second fund was raised by establishing an<br />
investment company, listed on the London Stock Exchange,<br />
under the venture capital trust regulations. This fund<br />
achieved a higher total return than any other venture<br />
capital trust, outperforming more than 30 other managers<br />
of venture capital trusts in a sector that has raised more<br />
than £2.5 billion over more than 10 years.<br />
<strong>Foresight</strong> has demonstrated the versatility of its<br />
investment expertise through successful management of<br />
two secondary portfolios. In 2004 the firm assumed the<br />
management of two funds, and delivered portfolio returns<br />
on the original assets of 53% and 55% respectively<br />
between 2004 and 2008.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
Key strengths of <strong>Foresight</strong>’s investment team<br />
<strong>Foresight</strong> believes that the range and depth of experience of<br />
its investment team is a critical success factor for the Fund and<br />
differentiates <strong>Foresight</strong> from other investment managers active in<br />
the target sector. This experience covers six key areas of particular<br />
relevance to the Fund:<br />
(i) Market knowledge<br />
Team members have an aggregate 35 years’ experience of the<br />
target markets. This enables <strong>Foresight</strong> to identify optimal market<br />
strategies and understand the way in which markets may evolve<br />
and the positioning and strategies of competitors.<br />
<strong>Foresight</strong> also has extensive experience of partnering and a<br />
network of contacts among potential partners. This may enable<br />
investee companies to gain advantage through partnering with<br />
organisations that have strong positions or strategic interests in<br />
the target sectors.<br />
(ii) Engineering procurement and operations management<br />
Team members have an aggregate 27 years of relevant experience<br />
in selection, procurement and operation of process infrastructure.<br />
Team members have procured and operated processes of the<br />
sort to be applied by the Fund, including energy recovery from<br />
waste, waste sorting, and manufacture of fuel from waste. This<br />
experience enables <strong>Foresight</strong> to identify areas of risk within<br />
investee company procurement plans and to recommend<br />
mitigation steps.<br />
(iii) Understanding planning and permitting regimes<br />
Obtaining planning consents is a key challenge for operators<br />
intending to establish recycling and renewable energy facilities.<br />
Through its experience of planning, extended by relationships with<br />
independent professionals, <strong>Foresight</strong> aims to control the costs and<br />
risk of the planning process. Team members have an aggregate of<br />
six years of experience in managing planning processes.<br />
(iv) Financing of projects and companies with both senior debt<br />
and equity<br />
Team members have an aggregate 117 years’ relevant experience,<br />
both in an advisory capacity as private equity investors and<br />
bankers and in a principal capacity as executives or non–executive<br />
directors of such companies.<br />
(v) Unquoted investment management<br />
Team members have 78 years of relevant experience gained as<br />
executives within private equity management firms. Through<br />
this experience, <strong>Foresight</strong> has developed expertise and firmlyestablished<br />
procedures for selecting, managing and realising<br />
unquoted investments.<br />
(vi) Team building<br />
Companies achieving high growth typically require an evolving<br />
set of skills from their management teams. Team members have<br />
extensive experience of leading and managing the process of<br />
management development to ensure that businesses continue to<br />
be managed effectively through periods of growth and change.
THE FUND STRATEGY wILL bE IMPLEMENTED bY A FOCUSED AND COMMITTED TEAM, COMPRISING<br />
FIVE PARTNERS AND THREE INVESTMENT MANAGERS.<br />
Partners and investment committee members<br />
Matt Taylor (age 47) joined <strong>Foresight</strong> in May 2000 and was<br />
appointed as a partner in April 2001. He is responsible for<br />
investor communications. Matt has 18 years’ experience in<br />
private equity investment management and three years’<br />
experience in European banking. Prior to joining <strong>Foresight</strong><br />
<strong>Group</strong>, Matt was a senior investment controller within 3i’s<br />
Midlands and South-west regional investment businesses,<br />
with responsibilities across investment management and the<br />
origination of investment opportunities. Over the course of<br />
nine years with 3i, he was involved in making or managing<br />
investments in 18 companies. Matt has also worked at IKb<br />
Deutsche Industriebank AG in Düsseldorf and started his career<br />
at Morgan Stanley International in London, where he was<br />
involved in the marketing and execution of M&A transactions<br />
and in the structuring and marketing of bond and equity issues.<br />
Andrew Page (age 41) joined <strong>Foresight</strong> in July 2004 and<br />
was appointed as a partner in September 2005. Andrew’s<br />
experience of process engineering has provided seminal<br />
influence to the development of the Fund strategy. He is<br />
responsible for guiding the engineering procurement and<br />
management activities of investee companies. Andrew has<br />
nine years’ experience in engineering management within the<br />
chemicals industry, where he was responsible for engineering<br />
and operations management within business units of Unilever<br />
and Dow, including maintenance and capital projects for<br />
chemicals manufacturing facilities. He gained a 1st Class<br />
honours degree in Mechanical Engineering at the University<br />
of Nottingham. Prior to joining <strong>Foresight</strong>, he was involved in<br />
making, managing or realising investments in 10 companies<br />
for 3i <strong>Group</strong> plc.<br />
Nigel Aitchison (age 42) joined <strong>Foresight</strong> in 2008 as a partner.<br />
He is responsible for market opportunity analysis and customer<br />
and supplier contracting. Prior to joining <strong>Foresight</strong>, Nigel was<br />
a board director of both Shanks waste Management Ltd,<br />
with annual turnover in excess of £130 million and employing<br />
over 800 people, and Shanks PFI Investments Limited, where<br />
he was until January 2008 responsible for all operational<br />
and business development functions related to projects<br />
financed under the Private Finance Initiative (PFI) for public<br />
procurement. Nigel has over 18 years’ experience in the waste<br />
management industry and significant experience of project<br />
finance. He has successfully completed two major PFI project<br />
financings for new waste facilities, raised over £150 million<br />
in bank financing, and held full profit and loss responsibility<br />
for a business with annual revenues of £45 million and in<br />
excess of 250 employees. He has also held overall commercial<br />
responsibility for the deployment of innovative residual<br />
waste treatment plants at commercial scale. Nigel is a<br />
Chartered Environmentalist.<br />
Bernard Fairman (age 60) is the chairman of <strong>Foresight</strong> and<br />
is responsible for group business development, strategy and<br />
administration, as well as having final responsibility for all<br />
significant investment decisions made on behalf of funds<br />
managed by <strong>Foresight</strong>. Over the past 25 years he has led<br />
<strong>Foresight</strong>’s development into a business that now manages<br />
over £300 million with more than 30 staff in the UK, Italy and<br />
Spain, and in 1997 launched the best ever performing venture<br />
capital trust. For ten years he was a director of smartcard<br />
innovator Gemplus, involved in its growth from start-up to over<br />
US$1 billion annual revenues.<br />
David Hughes (age 59) joined <strong>Foresight</strong> in July 2004 as a<br />
partner and is responsible for private equity and management<br />
of secondary portfolios. David has 29 years’ experience<br />
of unquoted investment management, initially with 3i and<br />
subsequently establishing fund management operations for<br />
Framlington Investment Management Ltd, baltic plc and bank<br />
Austria AG, London. David is a Chartered Certified Accountant<br />
with a 1st class degree in Chemistry from the University<br />
of bristol.<br />
Investment managers<br />
Giles Whitman (age 31) joined <strong>Foresight</strong> in 2007. He has<br />
three years’ experience in private equity and five years’<br />
experience in financial analysis and due diligence reporting.<br />
Prior to joining <strong>Foresight</strong>, he was a member of Ernst & Young’s<br />
Transaction Advisory Services team performing both corporate<br />
recovery and financial due diligence work. Giles is a Chartered<br />
Accountant and an Economics and Economic History graduate<br />
from bristol University.<br />
Tom Thorp (age 33) joined <strong>Foresight</strong> in 2008. Tom has<br />
two years’ experience in private equity and over five years’<br />
experience in financial analysis and due diligence reporting<br />
with KPMG’s Transaction Services and Restructuring teams<br />
both in London and Munich. Tom is a Chartered Accountant<br />
and graduated from Edinburgh University with a degree in<br />
business Studies and Accountancy.<br />
James Samworth (age 33) joined <strong>Foresight</strong> in 2009<br />
after a 10 year career at steel-maker Corus in operations<br />
management and leading key commercial accounts. He has<br />
investment experience within banking and private equity in<br />
the environmental, natural resources and industrial sectors,<br />
gained at Deutsche bank, Lyceum Capital Partners and Next<br />
wave Ventures. James is a first class Cambridge graduate<br />
with an MbA from London business School.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 13
14<br />
PART II - <strong>FORESIGHT</strong> ENVIRONMENTAL FUND LLP<br />
INVESTMENT MANAGEMENT<br />
Due diligence<br />
<strong>Foresight</strong>’s approach to due diligence is informed by in-depth<br />
understanding of the technical and market environment. This<br />
base of knowledge enables <strong>Foresight</strong> to focus investigation on<br />
key areas and to apply the insights gained through due diligence<br />
to guide strategy. The due diligence process includes research,<br />
analysis, referencing, site visits and direct contact with all<br />
key parties. <strong>Foresight</strong> typically employs external resources to<br />
supplement its own network and expertise, including lawyers,<br />
accountants, professional consultants and industry experts. Due<br />
diligence is focused on assessing and verifying all aspects of the<br />
opportunity including management capability and track record,<br />
market and competitive situation, sustainability, and engineering,<br />
technical, planning, financial and legal issues.<br />
Portfolio management<br />
<strong>Foresight</strong> seeks active involvement in investee companies,<br />
normally led by a member of <strong>Foresight</strong>’s investment team<br />
acting as a non-executive director of the investee company.<br />
A shareholders’ agreement will generally enable <strong>Foresight</strong> to<br />
control key aspects of the investee company’s activity. <strong>Foresight</strong><br />
expects to be central to decision-making in the following areas:<br />
n recruitment and incentivisation of key management and<br />
board members<br />
n definition and review of strategy and its implementation<br />
n fundraising from banks and other external sources<br />
n selection and procurement of process capital equipment<br />
n contracts for supply and off-take<br />
n mergers, acquisitions and exit<br />
Exit planning<br />
<strong>Foresight</strong> has extensive experience of achieving successful<br />
exits for investee companies. The relevant <strong>Foresight</strong> investor<br />
director is responsible for ensuring that exit planning is<br />
considered in a timely and professional manner, with regard to<br />
market cycles, the development stage and growth prospects<br />
of the investee company, and the requirements of investors.<br />
The Fund investment committee will regularly review the exit<br />
programme, providing insight and direction for the investor<br />
director. Evaluating the exit potential of each investment prior to<br />
the investment being made will be a key part of the investment<br />
process. Throughout the life of the investment, <strong>Foresight</strong> will<br />
remain active in determining the appropriate time and route to<br />
exit, always with a view to maximising cash distributions to the<br />
Fund’s investors. A typical exit strategy will be a sale to a strategic<br />
buyer or an initial public offering, both areas where <strong>Foresight</strong> has<br />
extensive experience.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
GOVERNANCE<br />
Investment committee<br />
All decisions of the Fund Manager in relation to the Fund will be<br />
made by the investment committee. The investment committee<br />
comprises bernard Fairman (chairman), Matt Taylor, Andrew<br />
Page, Nigel Aitchison and David Hughes. <strong>Foresight</strong> intends to<br />
appoint an additional non-executive member to the investment<br />
committee, who will add an independent viewpoint to decisionmaking.<br />
The investment committee is entitled to invite new<br />
members to join the investment committee when appropriate.<br />
The investment committee reaches its decisions by majority<br />
vote on the basis of written submissions prepared by members<br />
of <strong>Foresight</strong>’s investment team. All decisions of the investment<br />
committee will be formally recorded. The minutes of investment<br />
committee meetings and the initial appraisal and formal approval<br />
document in relation to each approved investment or disposal<br />
decision will be available for review by the Advisory Committee as<br />
soon as practical following the relevant decision or review.<br />
Advisory Committee<br />
The Fund will have an Advisory Committee comprising up to five<br />
representatives of Limited Partners. The Advisory Committee will<br />
be consulted by <strong>Foresight</strong> as Fund Manager on general policies,<br />
any proposed evolution of the investment strategy, any Key Man<br />
changes and any conflicts of interest.<br />
Members of the Advisory Committee do not act as agents of<br />
any Limited Partner and will not take part in the management<br />
of the Fund’s business. The approval or consent of the Advisory<br />
Committee permits, but does not commit, the Fund to take<br />
any action or make or dispose of any investment. Decisions of<br />
the Advisory Committee will be taken by vote of a majority or<br />
by written consent. Minutes will be taken of meetings of the<br />
Advisory Committee and circulated to each member of the<br />
Advisory Committee and to each Limited Partner.<br />
Members of the Advisory Committee will be nominated by<br />
Limited Partners in the Fund and appointed by the Fund Manager.<br />
No partner, employee or associate of the Fund Manager will be<br />
appointed to the Advisory Committee. The Fund Manager may<br />
attend and speak at meetings of the Advisory Committee but will<br />
not be entitled to vote.
TERMS APPLICAbLE TO <strong>FORESIGHT</strong><br />
ENVIRONMENTAL FUND LP<br />
The Cell’s investment in the Fund will be subject to the provisions<br />
of the Partnership Agreement and other legal documents relating<br />
to the Fund. The following summary of the Fund terms must be<br />
read subject to such documents. If there is any inconsistency<br />
between this summary and the Partnership Agreement, the<br />
provisions of the Partnership Agreement will prevail.<br />
Legal structure<br />
The Fund is an English limited partnership. One or more<br />
additional Parallel Funds may be created to accommodate<br />
specific investor requirements. The Fund and each Parallel Fund<br />
will invest pro rata to its share of Total Commitments.<br />
Investment policy<br />
The Fund will invest in unquoted companies engaged in the<br />
development, construction and operation of facilities for the<br />
treatment or recycling of waste, the manufacture of products<br />
from recycled materials, and the generation of renewable energy<br />
from waste. The Fund will invest to support construction of<br />
facilities in Greater London.<br />
The Fund will not invest more than 10% of Total Commitments<br />
(or 15% of Total Commitments with the consent of the Advisory<br />
Committee) in any single Portfolio Company and will not invest<br />
more than 25% of Total Commitments in investments linked by a<br />
common counterparty or stakeholder, in each case except where<br />
required to safeguard the assets of the Fund.<br />
The Investment Policy includes certain restrictions based on the<br />
rules of the European Regional Development Fund, including that:<br />
n investment in plant and equipment must represent a<br />
significant part of each investment,<br />
n investment must be consistent with the London Mayor’s<br />
waste strategy,<br />
n the Fund may not invest in incineration, and<br />
n investments must deliver certain levels of emission<br />
reduction, landfill diversion and job creation.<br />
Any variation of the Investment Policy will require approval of<br />
Fund Investors holding 75% of Total Commitments.<br />
Currency determinations<br />
All capital accounts of the Partners will be maintained on a<br />
pounds sterling basis.<br />
Term<br />
The term of the Fund will be ten years from the First Closing Date,<br />
but may be extended by up to two additional one year periods<br />
with the consent of the General Partner and a majority in interest<br />
of the Limited Partners. The Fund may be terminated earlier in<br />
certain circumstances, such as the bankruptcy or withdrawal of<br />
the General Partner.<br />
Closings<br />
Commitments to the Fund may be accepted at one or more<br />
closings. Investments made by the Fund between the First Closing<br />
Date and the Final Closing Date will be held for the benefit of<br />
all the Partners whether they become Partners at or after the<br />
First Closing Date. A Fund Investor making a Commitment or<br />
increasing its Commitment after the First Closing Date will be<br />
required to pay a cost of money premium to compensate for the<br />
delay in drawdown calculated at 4% per annum over LIbOR from<br />
the First Closing Date to the relevant date (an “Interest Charge”).<br />
The amounts drawn down from Limited Partners will be equalised<br />
to their pro rata share of Total Commitments by drawdown<br />
or return of Commitments. Any amounts returned to Limited<br />
Partners for the purposes of equalisation, excluding any interest,<br />
may be drawn down again during the Investment Period.<br />
Drawdown<br />
Commitments may be drawn down on not less than 10 business<br />
days’ notice by the Fund Manager, during the period commencing<br />
on the First Closing Date and ending on 31 December 2015<br />
(the “Investment Period”) for any purpose of the Fund, and<br />
thereafter during the term of the Fund for payment of the<br />
General Partner’s Share and costs of the Fund and for further<br />
investments in Portfolio businesses not exceeding 10% of Total<br />
Commitments. Notwithstanding the foregoing, to the extent<br />
that one or more investors notifies the Fund Manager that it is<br />
subject to a formal restriction imposed by a Regulatory body<br />
or Regulatory Requirement which prevents it from advancing<br />
amounts of its Commitment in certain circumstances after the<br />
end of the Investment Period, drawdown notices may only be<br />
issued to such investor up to an amount equal to the aggregate<br />
of Income Proceeds and Capital Proceeds previously distributed<br />
to such investor and an amount equal to a proportion of the<br />
interest received by the Fund in relation to any prepayment<br />
of such investor’s Commitment. Any amounts due from such<br />
investor after the end of the Investment Period with respect<br />
to payments on account of the General Partner’s Share and/or<br />
fees and expenses of the Fund which are not paid by an investor<br />
as a result of the foregoing restriction will be set off against<br />
and reduce future distributions to such investor. An investor<br />
that has notified the Fund Manager that it is subject to a formal<br />
restriction in relation to the payment of drawdowns after the<br />
end of the Investment Period and that is unable to fund its pro<br />
rata share of a follow-on investment made after the end of the<br />
Investment Period as a result of the restriction described above<br />
will be treated as an excused investor with respect to and will not<br />
participate in such follow-on investment.<br />
Amounts will be drawn down from each Limited Partner pro<br />
rata to their respective Commitments, except that if any<br />
Limited Partner is unable to fund a drawdown as a result of<br />
the restrictions described above or defaults on drawdown, the<br />
Fund Manager may draw down an amount equal to the unpaid<br />
or defaulted amount from the other Limited Partners pro rata<br />
to their respective Commitments. In no event will a Limited<br />
Partner be required to contribute any amount in excess of its<br />
Commitment. Any amount (i) drawn down and returned within<br />
12 months of drawdown, (ii) drawn down and returned and which<br />
relates to an investment that does not proceed to completion<br />
or (iii) representing an equalisation payment following the<br />
admission of additional investors, may be drawn down again<br />
during the Investment Period, provided that the aggregate<br />
amount so recalled from Limited Partners pursuant to (i) above<br />
shall not exceed 20% of Total Commitments.<br />
Default on drawdown<br />
If any Limited Partner fails to comply with a drawdown notice,<br />
interest will accrue on the resulting unpaid amount from the<br />
date of default at the greater of 8% per annum and 4% per<br />
annum above LIbOR. If the unpaid amount, plus interest thereon,<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 15
16<br />
PART II - <strong>FORESIGHT</strong> ENVIRONMENTAL FUND LLP<br />
is not paid within 30 days, the Fund Manager will have the<br />
right to cause the relevant Limited Partner to forfeit its Capital<br />
Contribution and 50% of the amount of its loan drawn down<br />
and not repaid (“Outstanding Loan”), and to cease being a<br />
Partner for all purposes, retaining only a right, subject to cash<br />
availability, to repayment of 50% of its Outstanding Loan after<br />
all other Limited Partners have received full repayment of their<br />
Outstanding Loans and subject to such deduction of any costs<br />
and expenses (including taxes) incurred by the General Partner,<br />
the Fund Manager or the Fund as a result of such Limited<br />
Partner’s default plus an amount equal to the General Partner’s<br />
Share that the General Partner would have been entitled to<br />
receive if such Limited Partner had not defaulted.<br />
Commitment fees<br />
The Fund Manager may require some (but not all) Limited<br />
Partners to pay a commitment fee on their admission to the<br />
Fund. Any commitment fees will be payable by the relevant<br />
Limited Partners in addition to and shall not form part of their<br />
Commitments. Commitment fees will be payable to the Fund<br />
Manager and may be on-paid by the Fund Manager to such<br />
third parties and introducers as the Fund Manager shall have<br />
agreed. Such amounts shall not be applied to reduce the General<br />
Partner’s Share. No commitment fee will be payable in respect of<br />
the Cell’s commitment to the Fund.<br />
Manner and timing of distributions<br />
Subject to the provisions for re-investment set out below, the<br />
income of the Fund received in cash, net of Fund costs, will be<br />
distributed as soon as practicable on a quarterly basis, and<br />
cash proceeds generated from the realisation of Investments<br />
generally will be distributed as soon as practicable after receipt<br />
by the Fund, but in any event within 60 days after such receipt;<br />
provided that in each case the General Partner may retain<br />
amounts in the Fund which it deems prudent for reserves to<br />
meet future costs or liabilities of the Fund or to offset amounts<br />
against contemporaneous drawdown requirements for costs<br />
or investment. Distributions in specie may be made of any<br />
Investment which is quoted or dealt on a recognised stock<br />
exchange or other appropriate market.<br />
Priority of distributions<br />
Distributions will be made in the following order of priority:<br />
First, to the General Partner in respect of any arrears of the<br />
General Partner’s Share or to repay any loan advanced to the<br />
General Partner by the Fund to pay the General Partner’s Share;<br />
Second, to the Limited Partners until they have received<br />
distributions equal in value to the sum of the amounts previously<br />
drawn down from Limited Partners to fund (i) Investments that<br />
have been either sold or written down (to the extent thereof)<br />
prior to the date of distribution, and (ii) costs of the Fund,<br />
including the General Partner’s Share;<br />
Third, to the Limited Partners until they have received<br />
distributions equal in value to a preferred return of 8% per<br />
annum (compounded annually) (the “Preferred Return”) on the<br />
excess of all amounts drawn down from Limited Partners prior to<br />
any date of distribution over all amounts distributed to Limited<br />
Partners prior to or on such date, from the relevant drawdown<br />
dates to the relevant dates of distribution. Any amounts<br />
returned to Limited Partners within 45 days of drawdown and<br />
any interest paid to the Fund by Limited Partners will not be<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
included in determining the Preferred Return;<br />
Fourth, to the Carried Interest Partner until the Carried Interest<br />
Partner has received (excluding any distributions under Second<br />
and Third above in respect of the Carried Interest Partner’s<br />
Commitment), distributions equal to 25% of the amount<br />
distributed under Third above; and<br />
Fifth, 80% to the Limited Partners (including the Carried<br />
Interest Partner in respect of its Commitment) and 20% to the<br />
Carried Interest Partner.<br />
Clawback<br />
After the final distribution of the assets of the Fund, the Carried<br />
Interest Partner will contribute to the Fund an amount equal<br />
to the greater of any Preferred Return Deficit and any Carried<br />
Interest Deficit, in each case as defined below, and this amount<br />
will be distributed to Limited Partners pro rata to their respective<br />
drawndown Commitments, provided that in no event will the<br />
Carried Interest Partner be required to contribute an amount<br />
in excess of the aggregate Carried Interest received less taxes<br />
paid in connection with such receipt. “Carried Interest” means all<br />
distributions received by the Carried Interest Partner excluding<br />
distributions in relation to its Commitment.<br />
A “Preferred Return Deficit” is an amount that is equal to any<br />
excess of the aggregate amounts drawn down from Limited<br />
Partners plus their Preferred Return through to the date of the<br />
final distribution over the aggregate amounts distributed to<br />
Limited Partners.<br />
A “Carried Interest Deficit” is an amount that is equal to any<br />
excess of the aggregate carried interest distributions during<br />
the term of the Fund over 20% of the Fund’s cumulative profit<br />
during the term of the Fund net of all losses and costs.<br />
Re-investment<br />
The Fund may re-invest any proceeds from the realisation of<br />
an Investment where such proceeds are (i) received by the<br />
Fund within 12 months of the completion of that Investment<br />
(ii) represent amounts allocated to the General Partner in<br />
satisfaction of loans made to the General Partner on account<br />
of the General Partner’s Share and (iii) proceeds arising from<br />
short-term investments made by the Fund, subject, in the case<br />
of sub-paragraphs (i) and (iii), to a maximum of 20% of Total<br />
Commitments.<br />
General Partner’s Share<br />
The General Partner will be entitled to an annual priority<br />
share of profits equal to 2% of Total Commitments, during the<br />
Investment Period and thereafter 2% of Total Commitments<br />
drawn down less the acquisition cost of Investments which (i)<br />
have been fully distributed in specie or (ii) have been realised<br />
in full, or (iii) have been written off, less any amounts owed by<br />
the Fund Manager to the Fund (the “General Partner’s Share”).<br />
The General Partner is responsible for the Fund Manager’s<br />
fees which it will satisfy from the General Partner’s Share. The<br />
General Partner’s Share, or drawings on account thereof, will be<br />
payable quarterly in advance from the First Closing Date.<br />
If the Fund’s profits are insufficient for payment of the General<br />
Partner’s Share, the Fund will advance to the General Partner<br />
amounts equal to the General Partner’s Share on an interest-free<br />
basis. The amount so advanced will be repaid from the General<br />
Partner’s Share but not otherwise.
The General Partner’s Share will be reduced by 80% of the<br />
value (net of any VAT or similar tax related thereto) of any fees<br />
received and retained by the General Partner, the Fund Manager<br />
and their Associates that are agreed upon at the time of and<br />
directly referable to the making of an Investment by the Fund.<br />
Costs<br />
The Fund will bear its establishment costs. The Fund will not<br />
pay any placement fees. The Fund will bear all other costs,<br />
such as legal, audit, printing, administration, banking, custody,<br />
taxation and other running costs of the Fund, and third-party<br />
costs associated with uncompleted transactions. Fund costs<br />
incurred on behalf of more than one of the Fund and any Parallel<br />
Fund will be borne by them in proportion to their share of Total<br />
Commitments. The General Partner and the Fund Manager will<br />
bear their own administrative costs and overhead expenses of<br />
managing the Fund and originating and monitoring Investments<br />
(“Ordinary Operating Costs”) and will not be entitled to recover<br />
these from the Fund.<br />
Third-party costs incurred in connection with consummated<br />
transactions other than Ordinary Operating Costs will be borne<br />
or reimbursed by the relevant Portfolio business.<br />
Fund Manager’s Commitment<br />
Certain <strong>Foresight</strong> staff will, through the Carried Interest Partner,<br />
make a Commitment to the Fund of 1% of Total Commitments as<br />
at the Final Closing Date.<br />
Exclusivity<br />
Unless approved by the Advisory Committee, the Fund Manager<br />
will not close or manage a new private equity investment fund<br />
for institutional investors for investment principally in the United<br />
Kingdom and having an investment policy substantially similar<br />
to that of the Fund until the earlier of the date on which at<br />
least 75% of the Fund’s Total Commitments have been invested<br />
or committed or allocated for specific investment or further<br />
financings of Portfolio Companies and the date on which the<br />
Investment Period expires or is terminated or is suspended<br />
following a Key Man departure.<br />
<strong>Foresight</strong> currently manages other funds, the investment<br />
policies of which include providing risk capital to companies<br />
involved in environmental infrastructure (each a “<strong>Foresight</strong><br />
Fund”). It is intended that the Fund and the <strong>Foresight</strong> Funds<br />
will enter into a co-investment allocation agreement pursuant<br />
to which each of the <strong>Foresight</strong> Funds will agree that the Fund<br />
Manager will allocate investment opportunities to the Fund in<br />
priority to the <strong>Foresight</strong> Funds. The exclusivity in favour of the<br />
Fund will not operate to prevent other <strong>Foresight</strong> Funds providing<br />
follow-on investment to their existing portfolio companies.<br />
Key Man and suspension<br />
If, during the Investment Period, (i) two or more of the Key<br />
Men cease for whatever reason to be appointed to the Fund<br />
Manager’s investment committee and “actively involved” in<br />
the affairs of the Fund and the Parallel Funds (and any other<br />
<strong>Foresight</strong> Funds that make investments in parallel with the Fund);<br />
or (ii) a change of control event occurs with respect to the Fund<br />
Manager, then, if decided by Limited Partners representing<br />
50% of Total Commitments, the Fund Manager shall not issue<br />
any further drawdown notices for the purposes of making new<br />
Investments. Following a vote of the Limited Partners to suspend<br />
drawdowns, the Investment Period shall terminate automatically<br />
if Limited Partners representing 50% of Total Commitments<br />
do not vote to approve the resumption of drawdowns within six<br />
months of the date that the suspension commenced. In the case<br />
of Matt Taylor, Andrew Page and Nigel Aitchison (and<br />
any replacement thereof approved by the Advisory Committee)<br />
“actively involved” means devoting substantially all of their<br />
business time to such matters and in relation to the Fund,<br />
allocating sufficient of such business time to such matters<br />
as to ensure the effective management of the Fund’s assets.<br />
In the case of bernard Fairman and David Hughes (and any<br />
replacement thereof approved by the Advisory Committee)<br />
“actively involved” means devoting sufficient of their business<br />
time to such matters as to ensure the effective management<br />
of the Fund’s assets and operation of the Fund Manager’s<br />
investment committee (envisaged to be 25% of time for bernard<br />
Fairman and 35% of time for David Hughes).<br />
Removal of the General Partner<br />
The appointment of the General Partner as the general partner<br />
of the Fund may be terminated if Fund Investors holding an<br />
aggregate of not less than 75% by value of Total Commitments<br />
vote to do so at a meeting of the Fund, at any time after two<br />
years from the Final Closing Date with compensation to the<br />
General Partner in the amount of the General Partner’s Share<br />
for the immediately preceding accounting period, or at any time<br />
without compensation in the event of its gross negligence, wilful<br />
misconduct, bad faith, material breach of contract which relates<br />
to the operation of the Fund, a material breach of any EU Rules<br />
or reckless disregard for its obligations and duties in relation to<br />
the Fund.<br />
Role of the Advisory Committee<br />
The Fund Manager will consult the Advisory Committee in<br />
relation to any potential conflict of interest, the nomination of<br />
any Key Man, general policies and guidelines of the Fund.<br />
Meetings and voting<br />
The Fund Manager will arrange a Partners’ meeting<br />
each year, at such time and place as it deems appropriate.<br />
Limited Partners holding 25% of Total Commitments<br />
may, by written notice to the Fund Manager, requisition<br />
the Fund Manager to call additional Partners’ meetings<br />
for a date no later than 28 days from the date of the relevant<br />
notice. Decisions taken at Partners’ meetings will require the<br />
approval of Partners (present in person or by proxy) whose<br />
aggregate Commitments represent in excess of 50 % of Total<br />
Commitments. If, however, the particular action would under the<br />
terms of the Partnership Agreement require a higher approval<br />
threshold such action shall only be validly adopted if also<br />
approved pursuant to such terms. All Partners will be entitled<br />
to participate in any vote or consent of the Limited Partners<br />
unless it is in default on a drawdown. Meetings of the Advisory<br />
Committee will be held when required.<br />
Material amendments<br />
The Partnership Agreement may be amended only with the<br />
written consent of the General Partner and Limited Partners<br />
representing 75% of Total Commitments voting at a Partners’<br />
meeting, provided that no amendment shall be made which (i)<br />
shall impose upon any Limited Partner any obligation to make<br />
any further payment to the Fund beyond the amount of its<br />
Commitment, (ii) increases the liabilities of or obligations of, or<br />
diminishes the rights of or protections of, a particular Limited<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 17
18<br />
PART II - <strong>FORESIGHT</strong> ENVIRONMENTAL FUND LLP<br />
Partner or a particular group of Limited Partners differently than<br />
the other Limited Partners, or (iii) otherwise modifies the limited<br />
liability of any Limited Partner, without the affirmative consent<br />
of all Limited Partners adversely affected thereby.<br />
Repayment of Commitments<br />
where a Limited Partner has notified the Fund Manager<br />
in writing that it is subject to an obligation imposed by a<br />
Regulatory body or a Regulatory Requirement requiring such<br />
Limited Partner to have a right to be repaid its Commitment,<br />
such Limited Partner shall have a right to demand repayment of<br />
all or any part of its drawn down Commitment (the “Regulatory<br />
Partner Repayment Right”) in certain circumstances. where<br />
a Limited Partner has exercised the Regulatory Partner<br />
Repayment Right, the relevant Limited Partner’s Commitment<br />
shall be immediately reduced by the amount of the drawn down<br />
Commitment repaid to such Limited Partner.<br />
Withdrawal and transfer of interests<br />
A Fund Investor may not withdraw from the Fund (whether by<br />
sale, transfer or assignment) without the prior written consent of<br />
the Fund Manager and only if such transfer does not breach any<br />
relevant legal or regulatory restriction.<br />
Indemnification<br />
Subject to certain limitations, the Fund will indemnify the<br />
General Partner, the Fund Manager and their respective<br />
partners, shareholders, contractors, employees, agents and<br />
affiliates against costs and expenses (including legal fees)<br />
incurred in connection with their activities on behalf of, or their<br />
association with, the Fund and any Portfolio business, except<br />
where such costs or expenses arose through conduct of such<br />
persons that constitutes fraud, negligence (having a material<br />
adverse effect on the Fund or the Fund Partners), material<br />
breach of contract, reckless disregard for their obligations and<br />
duties to the Fund or wilful misconduct. Neither the General<br />
Partner nor the Fund Manager will be liable to any Limited<br />
Partner or to the Fund for the negligence, dishonesty or bad<br />
faith of any agent acting for them or the Fund provided that<br />
such agent was selected and engaged with reasonable care.<br />
Governing law and jurisdiction<br />
The rights, obligations and relationships of the Partners<br />
will be governed by English law and the English courts shall<br />
have exclusive jurisdiction to settle any claims, actions or<br />
disputes arising in connection with or relating to the Fund, the<br />
Memorandum or the acquisition of interests in the Fund.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong>
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 19
20<br />
PART III - TAXATION<br />
GENERAL<br />
This summary is an introduction to some<br />
aspects of the tax position of the Cell<br />
and of individuals who hold Participating<br />
Shares (“Shareholders”). It is not<br />
intended to constitute legal or tax advice<br />
to investors. The tax consequences for<br />
each investor of investing in the Cell<br />
may depend upon the investor’s own<br />
tax position and upon the relevant<br />
laws of any jurisdiction to which the<br />
investor is subject. Prospective investors<br />
should familiarise themselves with,<br />
and where appropriate should consult<br />
their own professional advisors on, the<br />
consequences of subscribing, buying, or<br />
disposing of Participating Shares under<br />
the laws of any jurisdiction in which they<br />
may be liable to taxation. The statements<br />
in this section relate to investors entering<br />
into the Cell for investment purposes<br />
only and not for the purposes of any<br />
trade. There can be no guarantee that<br />
the tax position or proposed tax position<br />
prevailing at the time an investment in<br />
the Cell is made will endure indefinitely.<br />
The relevant Guernsey authorities may<br />
introduce revenue raising measures,<br />
including possibly the introduction of a<br />
goods and services tax, and may alter<br />
the tax regime to ensure continuing<br />
compliance with international standards.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
TAXATION OF THE COMPANY AND THE CELL<br />
Guernsey<br />
The Directors intend to apply for exempt status and to<br />
conduct the affairs of the Company and the Cell so as to<br />
ensure that it obtains and retains exempt status. Exempt<br />
companies (under the Income Tax (Exempt bodies)<br />
(Guernsey) Ordinance 1989 as amended) do not pay income<br />
tax in Guernsey on any income derived from sources<br />
outside Guernsey. Guernsey does not levy stamp duty or<br />
taxes upon capital, inheritances, capital gains or gifts.<br />
UK<br />
The Directors will seek to ensure that the Cell does not<br />
become resident in the UK for tax purposes, does not<br />
carry on a trade in the UK and is not centrally managed<br />
and controlled in the UK. On this basis, the Cell would not<br />
be subject to UK income tax or corporation tax other than<br />
on UK source income and would not be subject to any UK<br />
tax on its capital gains. Investment income arising from UK<br />
sources may be subject to UK withholding tax.<br />
ALL SHAREHOLDERS EXCEPT GUERNSEY<br />
RESIDENTS<br />
Shareholders resident outside Guernsey will not be subject<br />
to any tax in Guernsey in respect of the holding, sale or<br />
other disposition of Participating Shares. Dividends and<br />
all redemption proceeds may be paid by the Cell without<br />
withholding or deduction for Guernsey income tax.<br />
SHAREHOLDERS RESIDENT, ORDINARILY<br />
RESIDENT OR DOMICILED IN THE UK<br />
UK residents will be liable in the UK to income tax on<br />
dividends paid by the Cell and to capital gains tax on<br />
gains realised through disposal of Participating Shares.<br />
The Cell is not required to make any retention of tax<br />
from payments to UK resident individuals because the<br />
Cell is outside the scope of the EU Savings Directive. UK<br />
residents pay inheritance tax on their property, including<br />
Participating Shares, wherever situated.<br />
OFFSHORE REPORTING FUND STATUS<br />
The Cell is expected to be treated by HMRC as an offshore<br />
fund and therefore the Directors intend to make an<br />
application for the Cell to be certified as a reporting<br />
fund, in order to ensure that any gain realised on<br />
disposal or redemption of Participating Shares is treated<br />
as a capital gain and not as income for UK tax purposes.<br />
If the Cell is treated as an offshore fund and as a<br />
reporting fund, UK income tax would be charged on the<br />
Cell’s reported income and the Directors would seek to<br />
distribute sufficient of the Cell’s income to cover tax at<br />
the UK’s highest marginal income tax rate on all<br />
Participating Shares.
New regulations have been proposed by HMRC under which<br />
an offshore fund that is invested at least 90% by asset value<br />
in unlisted trading companies would not be required to be a<br />
reporting fund in order for gains realised on the disposal of<br />
shares in the fund to be treated as capital gains. As a limited<br />
partner in the Fund, the Cell is expected to invest at least<br />
90% of its asset value in unlisted trading companies through<br />
the Fund and Cell Investors could therefore benefit if the<br />
regulations are amended as proposed. However as the Cell<br />
will invest in unlisted trading companies over a period rather<br />
than immediately, it is possible that the Cell would continue<br />
to be regarded as an offshore fund as described in the<br />
preceding paragraph.<br />
ANTI-AVOIDANCE PROVISIONS<br />
Certain provisions of the Income Tax Act 2007 (“transfer<br />
of assets abroad rules”) could lead to UK income tax being<br />
charged on a Cell Investor’s share of the Cell’s income. These<br />
provisions affect income treated as arising to an individual<br />
who is ordinarily UK resident and who has the power to enjoy<br />
income of a person abroad as a result of a transfer of assets<br />
which results in that income becoming payable to that person<br />
abroad. These provisions are widely framed and may apply, in<br />
principle, to most ‘offshore funds’, but should not apply where<br />
the tax payer can establish that avoiding liability to taxation<br />
was not the purpose or one of the purposes for which the<br />
relevant transactions or any of them were effected.<br />
On 16 February 2011 the European Commission formally<br />
requested the UK to amend its transfer of assets abroad<br />
rules. This could lead to an improvement in the treatment<br />
of an investment made into the Cell by individuals who are<br />
ordinarily resident in the UK.<br />
SHAREHOLDERS wHO ARE RESIDENT IN THE UK<br />
bUT NOT DOMICILED IN THE UK<br />
The Participating Shares are expected to be classified as<br />
foreign assets for the purposes of UK capital gains tax and<br />
inheritance tax. Therefore, persons resident but not domiciled<br />
in the UK will be liable to capital gains tax only to the extent<br />
that capital gains are remitted to the UK. Dividends declared<br />
in respect of Participating Shares will be regarded as foreign<br />
sourced for the purposes of UK taxation. Therefore persons<br />
resident but not domiciled in the UK are expected to be<br />
liable to income tax only to the extent that the dividends are<br />
remitted to the UK. The statements in this paragraph assume<br />
that the Shareholder has claimed to be a remittance basis<br />
user and paid the charge/fee as appropriate.<br />
An individual who is not domiciled in the UK, and is not<br />
deemed to be domiciled there under special rules relating<br />
to long residence or previous domicile in the UK, is not<br />
generally within the scope of inheritance tax in relation to<br />
assets situated outside the UK. Participating Shares in the<br />
Cell should constitute assets situated outside the UK for<br />
inheritance tax purposes.<br />
MAJOR INVESTORS<br />
The Directors do not expect the Cell to be treated as a close<br />
company. However, if the Cell were to be treated as a close<br />
company in the UK, capital gains accruing to the Cell may be<br />
attributed to any UK resident Cell Investor who holds more<br />
than 10% of the Participating Shares (including holdings of<br />
any connected persons). The Cell Investor may then be liable<br />
to UK tax on capital gains on its proportionate interest in the<br />
Cell’s gains.<br />
STAMP DUTY AND SDRT<br />
No UK stamp duty or SDRT will be payable on the issue of<br />
the Participating Shares. The Participating Shares will not<br />
be registered in any register of the Cell kept in the UK, so<br />
that transfers of Participating Shares should not be subject<br />
to UK SDRT. UK stamp duty (at the rate of 0.5 per cent. of<br />
the amount of the value of the consideration for the transfer<br />
rounded up where necessary to the nearest £5) is payable on<br />
any instrument of transfer of Participating Shares executed<br />
within, or in certain cases brought into, the UK. Special rules<br />
apply to market makers, brokers, dealers, intermediaries<br />
and persons connected with depository arrangements or<br />
clearance services.<br />
SHAREHOLDERS RESIDENT IN GUERNSEY<br />
Shareholders who are resident for tax purposes in Guernsey,<br />
Alderney or Herm will incur Guernsey income tax on any<br />
dividends paid on shares owned by them but will suffer no<br />
deduction of tax by the Company from any such dividends<br />
payable by the Company (provided that the Company is<br />
granted tax exempt status as expected). The Company<br />
is required to provide details of distributions made to<br />
Shareholders resident in the Islands of Guernsey, Alderney<br />
and Herm to the Administrator of Income Tax in Guernsey.<br />
Stamp duty is payable on Guernsey grants of probate and<br />
letters of administration, which will generally be required to<br />
transfer Participating Shares on the death of a Shareholder.<br />
Stamp duty is levied according to the size of the estate and<br />
is payable on a sliding scale at a rate of up to 0.75% of the<br />
estate. Joint holders and holdings through a nominee are<br />
subject to different rules.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 21
22<br />
PART IV - RISK FACTORS<br />
THE FOLLOwING FACTORS ARE AMONG<br />
THE INVESTMENT CONSIDERATIONS<br />
THAT SHOULD bE CAREFULLY CONSIDERED<br />
bY PROSPECTIVE SHAREHOLDERS IN<br />
EVALUATING THE MERITS AND SUITAbILITY<br />
FOR THEM OF AN INVESTMENT IN THE<br />
CELL. THESE FACTORS SHOULD bE<br />
READ IN CONJUNCTION wITH THE<br />
SCHEME PARTICULARS.<br />
An investment in the Cell and the Fund<br />
involves a high degree of risk, and is<br />
illiquid and long-term. Prospective<br />
investors must therefore be able and<br />
willing to accept substantial risk and<br />
illiquidity. There can be no assurances<br />
or guarantees that the Cell’s or the<br />
Fund’s investment objectives will prove<br />
successful or that investors will not lose<br />
all or a portion of their investment in the<br />
Cell. It should be noted that the Cell’s<br />
performance will differ from the Fund<br />
as the Cell will bear its own fees and<br />
expenses and may also be affected by<br />
returns on the un-invested cash held by<br />
the Cell. In addition, income and capital<br />
gains paid to the Cell by the Fund may<br />
be retained by the Cell and the timing<br />
and amount of any distributions by the<br />
Cell may not be the same as the Fund.<br />
Prospective investors should consider<br />
all potential risk factors and evaluate<br />
these with their financial, legal and<br />
tax advisors before applying for<br />
Participating Shares.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
RISKS TO bE CONSIDERED INCLUDE, bUT<br />
ARE NOT <strong>LIMITED</strong> TO, THE FOLLOwING:<br />
ILLIQUIDITY<br />
The Cell will invest in the Fund, which is by its nature<br />
an illiquid investment with no certainty of return. The<br />
Participating Shares are not redeemable by Cell Investors.<br />
It is the intention of the Directors to seek a listing for the<br />
Participating Shares on the CISX as soon as practicable,<br />
but there is no guarantee that such a listing will occur. In<br />
any event there will be no active secondary market in the<br />
Participating Shares and the Directors do not anticipate<br />
that such a market will develop.<br />
Many of the Fund’s investments will be highly illiquid with<br />
no established market, and there can be no assurance<br />
that the Fund will be able to realise such investments in<br />
a timely manner. Fund investments may need to be held<br />
for a long period before they can be realised. Interests in<br />
the Fund will not ordinarily be transferable and may not<br />
be transferred, pledged or otherwise encumbered without<br />
the prior written consent of the Fund Manager in its sole<br />
discretion. There is no market for interests in the Fund and<br />
none is expected to develop. The Fund is not obliged to sell<br />
all or any portion of any assets or to retain any asset for<br />
the benefit of Limited Partners. The Fund is not obliged<br />
to redeem any Limited Partner’s interest, and Limited<br />
Partners will be required to remain in the Fund until it is<br />
terminated and dissolved. The timing of cash distributions<br />
to Limited Partners is uncertain, and distributions in kind<br />
of illiquid securities to the Limited Partners may be made.<br />
If the Fund becomes insolvent, Limited Partners may be<br />
required to return any property distributed to them at<br />
the time the Fund was insolvent, and forfeit any<br />
undistributed profits.<br />
Investors in the Fund, including the Cell, may in certain<br />
circumstances in the discretion of the General Partner<br />
receive securities owned by the Fund in lieu of cash.<br />
LACK OF DIVERSIFICATION<br />
The Cell will invest primarily in the Fund and the Fund’s<br />
portfolio will be concentrated in a limited number of<br />
investments and in a limited number of markets, and<br />
underperformance in any investment or adverse change in<br />
any market may result in the loss of a substantial portion<br />
of the Fund’s capital. If the Fund makes a bridging or<br />
underwriting investment with the intention of refinancing<br />
or selling a portion of the investment, there is a risk<br />
that the Fund will be unable to successfully complete<br />
such refinancing or sale. This could lead to increased<br />
risk as a result of the Fund having an unintended longterm<br />
investment and reduced diversification. The Fund’s
investment strategy is to limit its commitment to any<br />
single investment to 10% (or in certain cases 15%) of Total<br />
Commitments, but unforeseen events could lead to greater<br />
portfolio concentration. If the Fund raises less than £70<br />
million, the Fund may be subject to a number of adverse<br />
consequences, including less portfolio diversity and less<br />
capital for reserves. Consequently, the Fund may make<br />
smaller investments in order to diversify its portfolio,<br />
and may invest a greater portion of Commitments in<br />
initial investments.<br />
INAbILITY TO DEPLOY THE FUND OR TO DO SO ON<br />
ATTRACTIVE TERMS IN SUITAbLE <strong>INVESTMENTS</strong><br />
There is no assurance that the Fund will be able to identify and<br />
complete investments that are consistent with its investment<br />
strategy, or that it will be able to fully invest its available<br />
capital or that it will be able to do so in a timely manner. The<br />
Fund will compete in the acquisition of investments with other<br />
investors and this competition may result in increased cost<br />
of suitable investments. The identification of any potential<br />
investment or pipeline of investments is not an assurance<br />
that the Fund will complete any such investment. There is no<br />
assurance that any proposed investment will be made, that the<br />
terms of the investment will be the same or similar to those<br />
proposed from time to time or that any investment will be<br />
economically advantageous to the Fund.<br />
TRADING, MARKET AND PROJECT<br />
DEVELOPMENT RISKS<br />
Portfolio businesses will be subject to risks, including those<br />
associated with the general economic climate and local market<br />
conditions, changes in availability of materials or services<br />
required by, or demand for products or services offered by<br />
Portfolio businesses, onerous contracts, competition, litigation<br />
and other trading and market risks. There can be no assurance<br />
that Portfolio businesses will operate successfully.<br />
Fund investments may be subject to risks inherent in project<br />
development and construction. Projects may be subject to cost<br />
overruns and require more investment than planned. Projects<br />
may not be completed, or may be delayed during the planning,<br />
construction and commissioning phases.<br />
TAX, LEGAL AND REGULATORY CONSIDERATIONS<br />
An investment in the Cell involves complex tax, legal<br />
and regulatory considerations which may differ for each<br />
investor and each investor is advised to consult its own tax<br />
and legal advisers.<br />
The Fund may be subject to income or other tax. Local<br />
tax incurred in other jurisdictions by the Fund or Portfolio<br />
businesses may not be creditable to or deductible by<br />
Limited Partners.<br />
The Fund and its investments will be subject to laws and<br />
regulations imposed by the countries in which they operate.<br />
Any legislation and its interpretation or legal or regulatory<br />
regimes in relation to an investment in the Cell or the Fund<br />
may change during the life of the Cell. Enforcement of legal<br />
rights may prove expensive and difficult to achieve. Any<br />
change in laws or regulations, and any process of enforcing the<br />
Fund’s rights could have a material adverse effect on the Fund’s<br />
investments and on returns to Limited Partners including<br />
the Cell.<br />
LEVERAGE<br />
Portfolio businesses may incur indebtedness, in which case<br />
a third party would be entitled to certain senior ranking<br />
cashflows generated by such Portfolio businesses prior to the<br />
Fund receiving a return. while such leverage may increase<br />
returns or the funds available to any Portfolio business, it<br />
would also increase the risk of loss. If any Portfolio business<br />
defaults on any indebtedness, the Fund could lose its entire<br />
investment in that investee.<br />
LACK OF <strong>LIMITED</strong> PARTNER CONTROL OVER<br />
FUND MANAGEMENT, AND RELIANCE ON THE<br />
GENERAL PARTNER<br />
Limited Partners have no right to participate in the<br />
management of the Fund, or to make any decisions with<br />
respect to the investments made by the Fund, and have<br />
limited rights to remove the General Partner. The Fund and<br />
Limited Partners are totally dependent upon the General<br />
Partner. The General Partner will have full discretion to<br />
select investments, assess risks, negotiate terms of<br />
investment, and to manage and realise investments.<br />
The management, financing, distribution, operating and<br />
disposition policies of the Fund are determined by the General<br />
Partner. These policies may be changed from time to time at<br />
the discretion of the General Partner without a vote of the<br />
Limited Partners. Any such changes could be detrimental to<br />
the value of the Fund.<br />
Failure by the General Partner to manage investments<br />
effectively could have a material adverse effect on the Fund’s<br />
investments and on returns to Limited Partners. There is<br />
no assurance that the General Partner can effectively<br />
manage investments.<br />
The ability of the General Partner to successfully manage the<br />
Fund depends on the experience, relationships and expertise<br />
of <strong>Foresight</strong>’s investment team. Significant change in the<br />
investment team could impair the Fund’s ability to select<br />
attractive investments and manage its investment effectively.<br />
There can be no assurance that any individual will continue to<br />
be able to carry on their current duties throughout the term<br />
of the Fund.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 23
24<br />
PART IV – <strong>FORESIGHT</strong> ENVIRONMENTAL FUND LLP<br />
LIMITATION OF LIAbILITY AND INDEMNIFICATION<br />
The Partnership Agreement limits circumstances under<br />
which the General Partner, the Manager, and their<br />
respective partners, officers, directors, shareholders,<br />
employees, agents and affiliates can be held liable to<br />
the Fund. As a result, Limited Partners may have a more<br />
limited right of action in certain cases than they would in<br />
the absence of these provisions. In addition, the General<br />
Partner, the Manager and its partners, officers, directors,<br />
shareholders, employees, agents and affiliates will be<br />
entitled to indemnification from the Fund, except in certain<br />
circumstances. The assets of the Fund will be available<br />
to satisfy these indemnification obligations and such<br />
obligations will survive the dissolution of the Fund.<br />
RECOURSE TO ALL FUND ASSETS<br />
The assets of the Fund, including any investment made<br />
by it and any capital held by it, are available to satisfy all<br />
liabilities and other obligations of the Fund. If the Fund<br />
becomes subject to a liability, parties seeking to have the<br />
liability satisfied may have recourse against the Fund’s<br />
assets generally, and may not be limited to any particular<br />
asset, such as the investment giving rise to liability.<br />
STAGING OF COMMITMENTS AND DRAwDOwNS,<br />
DEFAULT PROVISIONS AND USE OF CAPITAL<br />
Commitments to the Fund may be accepted at any time<br />
between the First Closing Date and the Final Closing Date<br />
and will be drawn down over time. Investors who commit to<br />
the Fund after the Fund First Closing Date may have more<br />
information about the Fund’s investments and intentions<br />
than earlier investors. As a result, the earlier investors<br />
may be subject to higher risks than the later investors.<br />
If the Fund is unable to raise sufficient Commitments, or<br />
any Limited Partner fails to contribute any portion of its<br />
Commitment on a timely basis, the Fund’s ability to achieve<br />
appropriate portfolio diversity or to provide further funds to<br />
Portfolio businesses may be affected, which could adversely<br />
affect the Fund’s returns on investments.<br />
Any Limited Partner which fails to comply with a notice<br />
of drawdown may suffer significant financial penalties.<br />
If a Limited Partner defaults, it may be subject to various<br />
remedies as provided in the Partnership Agreement,<br />
including a forfeiture of its interests in the Fund.<br />
If the Fund is unable to generate a return on investment<br />
early in the life of the Fund to defray expenses (including<br />
without limitation the General Partner’s Share), those fees<br />
and expenses will have to be paid from the drawdown<br />
of Commitments.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
POTENTIAL CONFLICTS OF INTEREST<br />
There may arise situations where the interests of the Cell<br />
or the Fund conflict with interests of other funds managed<br />
by <strong>Foresight</strong> or with those of members of <strong>Foresight</strong>’s<br />
investment team. <strong>Foresight</strong> provides services both to the<br />
Fund (in its role as Fund Manager) and indirectly to the<br />
Company (in its roles as Investment Advisor and Investment<br />
Manager in relation to <strong>Foresight</strong> Environmental Cell.<br />
Conflicts may arise between the interests of the Fund, the<br />
Company and <strong>Foresight</strong> Environmental Cell and decisions<br />
made by <strong>Foresight</strong> may be more beneficial for one of these<br />
parties than for any other.<br />
The Fund is expected to invest in companies in which other<br />
funds managed by the Fund Manager hold investments.<br />
Decisions made by <strong>Foresight</strong> may be more beneficial for one<br />
fund managed or advised by <strong>Foresight</strong> than for any other.<br />
The Fund may co-invest with third parties through joint<br />
ventures or other entities. Such investments may give<br />
rise to the possibility that a co-investor or partner may<br />
at any time have economic or business interests or goals<br />
which are inconsistent with those of the Fund, or that<br />
such person may to take action contrary to the Fund’s<br />
investment objectives.<br />
The entitlement of the Carried Interest Partner to Carried<br />
Interest creates an incentive for the Fund Manager to make<br />
more speculative investments on behalf of the Fund than it<br />
would otherwise make in the absence of such performancebased<br />
compensation arrangements.<br />
<strong>Foresight</strong> may enter into fee sharing arrangements with<br />
third party marketers, including placement agents, or<br />
other advisers who refer investors to the Fund, and such<br />
marketers may have a conflict of interest in advising<br />
prospective investors whether to make commitments<br />
to the Fund.<br />
Conflicts of interest may arise in connection with decisions<br />
made by the Fund Manager that may be more beneficial<br />
for certain Limited Partners than for any other. In making<br />
such decisions, the Fund Manager intends to consider<br />
the investment objectives of the Fund as a whole, not the<br />
investment objectives of any individual Limited Partner.<br />
The Fund Manager may provide certain Limited Partners<br />
with the opportunity to co-invest in any Fund investment.<br />
Potential conflicts may be inherent in, or arise from, the<br />
Fund Manager’s discretion in providing such opportunities<br />
to certain Limited Partners. In addition, once such coinvestments<br />
are made, the Fund’s interests and those of<br />
co-investing Limited Partners may subsequently diverge.
FRAUD<br />
The Fund could be subject to losses due to fraudulent<br />
and negligent acts on the part of third parties, including<br />
borrowers, brokers, sellers and vendors.<br />
<strong>LIMITED</strong> REGULATORY OVERSIGHT<br />
The Fund is not subject to monitoring or oversight by any<br />
regulatory body. Consequently, Limited Partners will not<br />
benefit from protections which might be afforded by such<br />
monitoring or oversight of the Fund’s investment activities.<br />
NO SEPARATE COUNSEL<br />
Neither the Partnership Agreement nor any other<br />
agreements, contracts and arrangements between or<br />
among the Fund, the General Partner, the Fund Manager<br />
or any affiliate were or will be the result of arms length<br />
negotiations. The advisers who have performed services<br />
for the Cell or the Fund in connection with this offering,<br />
and who will perform services for the Cell or the Fund in<br />
the future, have been and will be selected by <strong>Foresight</strong>.<br />
No independent counsel has been retained to represent<br />
the interests of investors or Limited Partners, and the<br />
Partnership Agreement has not been reviewed by any<br />
attorney on their behalf. Any prospective investor is<br />
therefore urged to consult its own counsel as to the terms<br />
and provisions of the Partnership Agreement and all other<br />
related documents.<br />
The advisers to the Fund, the General Partner or the<br />
Fund Manager will not oversee or monitor the Fund’s<br />
investment activities and Limited Partners should not<br />
rely on them to do so.<br />
REPAYMENT OF COMMITMENTS<br />
The Fund’s constitutional documents include provisions<br />
enabling an investor that is subject to specific regulatory<br />
restrictions to demand the early repayment of its drawn<br />
down Commitments in certain circumstances. These<br />
provisions do not alter the rights of all investors to share<br />
in distributions from the Fund. However, if such a demand<br />
is made, the Fund may be required to sell some or all of<br />
its investments earlier than intended and that in these<br />
circumstances the proceeds from the sale of investments<br />
may be significantly lower than from a sale of the same<br />
investments in the ordinary course of business.<br />
DETERMINATION OF NET ASSET VALUE<br />
Adequate information relating to the Fund may not always<br />
be available to the Administrator and consequently the<br />
published Net Asset Value may not accurately reflect the<br />
value of the Cell’s holdings or the value that would have<br />
been received by the Cell had those holdings been realised<br />
on that day.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 25
26<br />
PART V – DEFINITIONS<br />
SAVE AS PROVIDED bELOw, wORDS AND EXPRESSIONS DEFINED IN THE SCHEME PARTICULARS<br />
SHALL HAVE THE SAME MEANINGS HEREIN. IN THESE CELL PARTICULARS, THE FOLLOwING<br />
wORDS SHALL HAVE THE MEANINGS OPPOSITE THEM UNLESS THE CONTEXT IN wHICH THEY<br />
APPEAR REQUIRES OTHERwISE:<br />
“1933 Act” United States of America Securities Act of 1933, as amended;<br />
“1940 Act” United States of America Investment Companies Act of 1940, as amended;<br />
“Administrator” JTC Fund Services (Guernsey) Limited or such other entity as may from time to time be<br />
appointed by the Investment Manager;<br />
“Advisory Committee” a committee of the Fund comprising representatives of certain Fund Investors appointed by<br />
the Fund Manager;<br />
“Application Form” the application form, materially in the form provided in this document (or in such other<br />
form reasonably determined by the Investment Manager) in respect of the First Offer or the<br />
Second Offer to be entered into by a prospective Cell Investor pursuant to which it applies to<br />
become a shareholder, directly or indirectly, in the Cell;<br />
“Application Period” The First Offer Application Period or the Second Offer Application Period as the<br />
context requires;<br />
“Associate” Companies that are associated to one another as a consequence of (i) one being a subsidiary<br />
of another, or (ii) both being subsidiaries of the same company;<br />
“Business Day” a day on which banks in Guernsey are open for normal banking business (excluding<br />
Saturdays and Sundays);<br />
“Carried Interest” A performance incentive in respect of the Fund payable to the Carried Interest Partner and<br />
summarised under “Priority of distributions” on page 16;<br />
“Carried Interest Partner” <strong>Foresight</strong> Environmental FP LP;<br />
“Cell” the <strong>Foresight</strong> Environmental Cell, the cell of the Company to which these Cell<br />
Particulars relate;<br />
“Cell Investor” A shareholder in the Cell;<br />
“CISX” Channel Island Stock Exchange, LbG;<br />
“Commitment” an amount committed by a Limited Partner to the Fund, comprising a capital contribution,<br />
being 0.001% of such Commitment, and an interest-free loan to the Fund, being 99.999% of<br />
such Commitment; and Total Commitments means the aggregate of all Commitments;<br />
“Company” <strong>Foresight</strong> Investments <strong>PCC</strong> Limited;<br />
“Directors” the board of directors of the Company;<br />
“First Offer” an offer to subscribe for up to 2,176,000 no par value Participating Shares during the First<br />
Offer Application Period with a minimum investment per Cell Investor of £10,000;<br />
“First Offer Application Period” the period commencing on 30 May 2011 and ending on 29 July 2011 or such other date or<br />
dates as the Directors may determine in their discretion, during which period applications for<br />
Participating Shares under the First Offer may be accepted;<br />
“<strong>Foresight</strong>” the Investment Manager, the Fund Manager and/or their Associates as the context requires;<br />
“<strong>Foresight</strong> Environmental Fund LP” an English limited partnership with registered number LP14322, together with any parallel or<br />
alternative investment vehicles established from time to time to invest alongside the same<br />
and including any successors or assigns thereof;<br />
“Fund” <strong>Foresight</strong> Environmental Fund LP and any Parallel Fund;<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong>
“Fund Final Closing Date” the latest date upon which a Fund Investor is admitted to or increases its Commitment to the<br />
Fund which is not later than 12 months after the Fund First Closing Date;<br />
“Fund First Closing Date” the date upon which the first Fund Investor was admitted to the Fund, being 3rd March 2011;<br />
“Fund Investor” a Partner, other than the General Partner and the Carried Interest Partner;<br />
“Fund Manager” <strong>Foresight</strong> <strong>Group</strong> LLP, which is the manager of <strong>Foresight</strong> Environmental Fund LP and is<br />
authorised and regulated by the Financial Services Authority (registered number 198020);<br />
“General Partner” the general partner of <strong>Foresight</strong> Environmental Fund LP being <strong>Foresight</strong> Environmental GP<br />
LP, a Scottish limited partnership with registered number 8691, or its successors and assigns,<br />
acting in its capacity as the general partner to <strong>Foresight</strong> Environmental Fund LP;<br />
“General Partner’s Share” the priority profit share entitlement of the General Partner in respect of <strong>Foresight</strong><br />
Environmental Fund LP from time to time (or the equivalent fee or entitlement where not<br />
structured as a priority profit share), as summarised under “General partner’s share” on<br />
page 17;<br />
“Interest Charge” an amount paid by the Cell to the Fund to reflect the fact that the Cell is admitted to the<br />
Fund after the Fund First Closing Date, and calculated at 4% per annum over LIbOR on any<br />
amounts that would have been drawn down by the Fund from the Cell if the Cell had made its<br />
commitment to the Fund at the Fund First Closing Date;<br />
“Investment” an investment made or held by the Fund in a Portfolio business;<br />
“Investment Manager” <strong>Foresight</strong> <strong>Group</strong> CI Limited, a limited company registered in Guernsey with number 51471 (or<br />
its successors and assigns);<br />
“Investment Management the agreement dated 19 May 2011 between the Cell and the Investment Manager appointing<br />
Agreement” the Investment Manager as investment manager of the Cell;<br />
“Investment Period” the investment period of the Fund, being the period commencing on the Fund First Closing<br />
Date and ending on 31 December 2015;<br />
“Investment Policy” the investment policy of the Fund, as summarised in Part I of this document;<br />
“Key Man or Key Men” Matt Taylor, Andrew Page, Nigel Aitchison, bernard Fairman, David Hughes or any other person<br />
approved by the Advisory Committee;<br />
“LIBOR” the London Interbank Offered Rate for three–month Sterling deposits published by bloomberg<br />
on any relevant business day;<br />
“Limited Partner” a limited partner in the Fund or any Parallel Fund. The Cell will be a Limited Partner in<br />
the Fund;<br />
“Net Asset Value” (i) when applied to the Cell, the net asset value of the Cell, calculated by deducting the total<br />
liabilities of the Cell from the total assets of the Cell (and, in calculating the value of the assets<br />
of the Cell, this will be determined with reference to the valuations of <strong>Foresight</strong> Environmental<br />
Fund LP which will be determined by the Fund Manager in its reasonable discretion in<br />
accordance with the “International Private Equity and Venture Capital Valuation Guidelines”<br />
produced by the bVCA, EVCA and AFIC in October 2006, or any replacement thereof); or<br />
(ii) when applied to the Company, the net asset value of the Company calculated by deducting<br />
the total liabilities of the Company from the total assets of the Company;<br />
“Parallel Fund” a fund or similar entity established under agreements containing commercial terms similar to<br />
the Partnership Agreement;<br />
“Partner” a partner in the Fund or any Parallel Fund;<br />
“Partnership Agreement” the partnership agreement constituting the Fund;<br />
“Participating Shares” participating preference shares in the Cell;<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 27
28<br />
DEFINITIONS<br />
“Portfolio Business” a company or other entity, or a group of companies or other entities linked (directly or<br />
indirectly) by common management, in which the Fund holds an Investment;<br />
“Qualified Investor” (i) legal entities which are authorised or regulated to operate in the financial markets,<br />
including: credit institutions, investment firms, other authorised or regulated financial<br />
institutions, insurance companies, collective investment schemes and their management<br />
companies, pension funds and their management companies, commodity dealers, as well<br />
as entities not so authorised or regulated whose corporate purpose is solely to invest<br />
in securities; (ii) national and regional governments, central banks, international and<br />
supranational institutions such as the International Monetary Fund, the European Central<br />
bank, the European Investment bank and other similar international organisations; and<br />
(iii) other legal entities, which, according to their last annual or consolidated accounts, meet<br />
at least two of the following three criteria: an average number of employees during the<br />
financial year of 250 or more, a total balance sheet exceeding €43,000,000 and an annual<br />
net turnover exceeding €50,000,000;<br />
“Regulatory Body” any UK or EU government department, body, institution or agency and/or any other<br />
regulatory body, institution or agency whether local, regional, national and/or European<br />
and including, but not limited to, the London Development Agency, the London waste and<br />
Recycling board, the Department for Communities and Local Government, the National Audit<br />
Office, the UK Government, the European Commission, the Court of Justice of the European<br />
Union, the Court of Auditors of the European Union and/or any successor such department,<br />
agency or regulatory body which, whether under Regulatory Requirements, codes of<br />
practice or otherwise is entitled to regulate, investigate, or influence any of the matters dealt<br />
with in the Partnership Agreement or the affairs of any party to it or person mentioned in it;<br />
“Regulatory Requirements” all or any of the following:-<br />
i) Acts of Parliament and any statutory instruments, rules, orders, regulations, notices<br />
directions, bye laws and permissions for the time being made under or deriving validity from<br />
an Act of Parliament (including but not limited to those implementing EU Rules); ii) EU Rules<br />
and rules having the force of law in the United Kingdom; and iii) regulations, orders, bye-laws,<br />
codes of practice or any requirement of, or obligation imposed by, any Regulatory body;<br />
“Second Offer“ the offer for an unlimited number of no par value Participating Shares during the Second<br />
Offer Application Period with a minimum investment per Cell Investor of £43,500;<br />
“Second Offer Application Period” the period commencing on 31 May 2011 and ending on 29 July 2011 or such other date or<br />
dates as the Directors may determine in their discretion, during which period applications for<br />
Participating Shares under the Second Offer may be accepted;<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong>
“US Person” For the purpose of these Cell Particulars, but subject to such applicable law and to such<br />
changes as may be notified by the Investment Manager to applicants for Participating Shares<br />
and transferees, “US Person” shall have the same meaning as in Regulation S, as amended<br />
from time to time, of the 1933 Act. Regulation S currently defines a “US Person” as: (a) any<br />
natural person who is a resident of the United States; (b) any partnership or corporation<br />
organised or incorporated under the laws of the United States; (c) any estate of which any<br />
executor or administrator is a US Person as defined in sub-paragraphs (a) and (b) herein;<br />
(d) any trust of which any trustee is a US Person as defined in sub-paragraphs (a) and (b)<br />
herein; (e) any agency or branch of a foreign entity located in the United States; (f) any nondiscretionary<br />
account or similar account (other than an estate or trust) held by a dealer or<br />
similar fiduciary for the benefit or account of a US Person; (g) any discretionary account or<br />
similar account (other than an estate or trust) held by a dealer or other fiduciary organised,<br />
incorporated or, if an individual, resident in the United States; or (h) any partnership or<br />
corporation (i) if organised or incorporated under the laws of any foreign jurisdiction and (ii)<br />
formed by a US Person principally for the purpose of investing in securities not registered<br />
under the 1933 Act, unless it is organised or incorporated, and owned, by accredited investors<br />
(as defined in Rule 501(a) under the 1933 Act) who are not natural persons, estates or trusts.<br />
“US Person” does not include: (a) a discretionary account or similar account (other than<br />
an estate or trust) held for the benefit or account of a non-US Person by a dealer or other<br />
professional fiduciary organised, incorporated or, if an individual, resident in the United States;<br />
(b) any estate of which any professional fiduciary acting as executor or administrator is a<br />
US Person if (i) an executor or administrator of the estate who is not a US Person has sole<br />
or shared investment discretion with respect to the assets of the estate and (ii) the estate is<br />
governed by foreign law; (c) any trust of which any professional fiduciary acting as trustee<br />
is a US Person if a trustee who is not a US Person has sole or shared investment discretion<br />
with respect to the trust assets, and no beneficiary of the trust (and no seller if the trust<br />
is revocable) is a US Person; (d) an employee benefit plan established and administered in<br />
accordance with the law of a country other than the United States and customary practices<br />
and documentation of such country; or (e), any agency or branch of a US Person located<br />
outside the United States if (i) the agency or branch operates for valid business reasons and<br />
(ii) the agency or branch is engaged in the business of insurance or banking and is subject to<br />
substantive insurance or banking regulation, respectively, in the jurisdiction where located.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 29
30<br />
APPLICATION FORM FOR<br />
<strong>FORESIGHT</strong> ENVIRONMENTAL CELL<br />
bEFORE COMPLETING THIS APPLICATION FORM YOU ARE STRONGLY RECOMMENDED TO CONSULT<br />
AN INDEPENDENT FINANCIAL ADVISER AUTHORISED UNDER THE FINANCIAL SERVICES AND<br />
MARKETS ACT 2000 OR UNDER RELEVANT LEGISLATION IN YOUR JURISDICTION.<br />
COMPLETE THE FORM IN bLOCK CAPITALS.<br />
ALL APPLICANTS MUST<br />
Sign either Section 1 or Section 6.<br />
Sign the Declaration in Section 2.<br />
Include a cheque/bankers draft (unless paying by<br />
electronic transfer).<br />
If paying by electronic transfer, send the completed<br />
instruction in Section 4 to your bank and attach a copy<br />
of the instruction to your Application Form.<br />
Keep a copy of the completed Application Form for<br />
your records.<br />
Send the completed Application Form by post to:<br />
JTC Fund Services (Guernsey) Limited, La Plaiderie<br />
House, La Plaiderie, St. Peter Port, Guernsey, GY1 1WF to<br />
be received by 5pm on 29 July 2011 (or such other date<br />
or dates as the Directors may determine in respect of<br />
the First Offer and the Second Offer at their discretion).<br />
Cleared funds for the investment amount entered on the<br />
Application Form must be received by 5pm on 29 July<br />
2011 (or if the relevant Application Period is altered,<br />
then on the Business Day prior to expiry of the relevant<br />
Application Period). If payment is not received in due<br />
time the application may be rejected. All cheques and<br />
banker’s drafts will be presented for payment on receipt.<br />
In this Application Form, we refer to “CERTIFIED COPIES”.<br />
This means that the copy documents requested must be<br />
certified by a person such as a solicitor/notary public/<br />
accountant/banker/local police officer or other professional<br />
person. Corporate documents may be certified by<br />
the corporate secretary or a director or officer of the<br />
corporation. Documents cannot be certified by the Applicant.<br />
The person certifying the copy document must<br />
(i) mark the copy document as “a true and exact copy of the<br />
original, which I have seen” and<br />
(ii) where the document concerned contains a photograph<br />
as proof of identity, confirm that “the photograph is a true<br />
likeness of the person named in the document”, and<br />
(iii) sign and date the copy document, stating in what<br />
capacity they are acting.<br />
The Company will decide, in its absolute discretion, to accept<br />
or reject your application made on this form under the terms<br />
of the First Offer or the Second Offer (as relevant) and will<br />
notify you of its decision. If your application is accepted, a<br />
written confirmation of acceptance will be sent to you.<br />
IF YOu DO NOT RECEIVE AN ACKNOwLEDgEMENT OF YOuR APPLICATION wIThIN 10<br />
DAYS OF SENDINg IT, PLEASE CONTACT:<br />
JTC FuND SERVICES (guERNSEY) <strong>LIMITED</strong> +44 (0)1481 702400<br />
Applications for Participating Shares will only be accepted from prospective investors in respect of whom <strong>Foresight</strong><br />
undertakes an adequate assessment of his or her expertise, experience and knowledge which gives reasonable assurance,<br />
in light of the contents of this document, that the prospective investor is capable of making his or her own investment<br />
decisions and understands the risks involved. If an applicant has been advised by an authorised intermediary who is<br />
able to advise on investments in overseas companies and who completes the letter of introduction in Section 5 of this<br />
Application Form, the applicant will be treated as having satisfied the above criteria.<br />
If any application is not accepted, the amount paid on application will be returned, without interest, if the payment<br />
was by way of cheque, by post to the first address given in the application or, if the payment was made by way of<br />
electronic transfer, by return transfer less any charges to the account of the remitter at the remitting bank quoting<br />
the applicant’s name, in each case at the applicant’s risk.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong>
SECTION 1 COMPLETE THIS SECTION IF THE<br />
APPLICANT IS AN INDIVIDUAL<br />
Email:<br />
INDIVIDUALS CAN ONLY APPLY ON THEIR OwN bEHALF AND IN THEIR OwN NAME<br />
Title: Forenames:<br />
Surname: Other names:<br />
Nationality: Date of birth:<br />
Permanent residential address:<br />
Post Code:<br />
Country: Email:<br />
Telephone: Alternative Tel:<br />
Please tick here if the applicant is resident in Guernsey for tax purposes<br />
FIRST OFFER - MINIMUM £10,000<br />
Investment amount: £<br />
I wish to invest the above amount in the <strong>Foresight</strong> Environmental Cell of <strong>Foresight</strong> Investments <strong>PCC</strong> Limited on the basis of the<br />
Scheme Particulars and the Cell Particulars under the terms of the First Offer or the Second Offer.<br />
PLEASE SIGN bELOw<br />
SECOND OFFER - MINIMUM £43,500*<br />
Investment amount: £<br />
Signature: Please print name**: Date:<br />
Information such as annual reports of the Cell will be sent by email to the email address shown above. If you prefer to receive paper<br />
copies please tick this box. q<br />
Notes:<br />
* The minimum amount under the SECOND OFFER is reduced to £10,000 if the Applicant is:<br />
(a) one of up to 99 persons to whom the Second Offer was specifically made or directed by <strong>Foresight</strong> with a statement to that effect<br />
clearly affixed to the Application Form; or<br />
(b) a Qualified Investor acting on its own behalf or on behalf of a person who has engaged the Qualifying Investor to act as his agent<br />
on terms which enable the Qualified Investor to make decisions concerning the acceptance of offers of transferable securities on<br />
that person’s behalf without reference to that person.<br />
** If the form is signed for the Applicant by an attorney or other agent, that person should state here the capacity in which they<br />
are signing and should send the original power(s) of attorney (or a copy certified by a solicitor) with the Application Form. Original<br />
documents will be returned as soon as practicable at the Applicant’s risk.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 31
32<br />
SECTION 2<br />
DECLARATION<br />
Email:<br />
PLEASE READ THIS DECLARATION CAREFULLY AND SIGN<br />
• I/we confirm that I/we have read and understood the Scheme Particulars and the Cell Particulars.<br />
• I/we understand that the Directors have discretion to refuse to accept applications under the terms of the First Offer and<br />
the Second Offer in whole or in part.<br />
• I/we acknowledge that the Directors reserve the right should it be necessary, to allocate applications between the First<br />
Offer and the Second Offer as they see fit.<br />
• In respect of applications made under the Second Offer, I/we confirm that I/we are:<br />
(a) one of up to 99 persons to whom the Second Offer was specifically made or directed by or on behalf of the Company or by<br />
its duly authorised agents; or<br />
(b) making an application for at least £43,500; or<br />
(c) a Qualified Investor (as defined in the Cell Particulars); or<br />
(d) a Qualified Investor acting on behalf of a person who has engaged the Qualified Investor to act as his agent on terms<br />
which enable the Qualified Investor to make decisions concerning the acceptance of offers of transferable securities of that<br />
person’s behalf without reference to that person.<br />
• I/we understand that I/we may be required to provide further information in connection with my/our application and<br />
that failure to provide the requested information may result in my/our application being treated as invalid or in delay of<br />
confirmation.<br />
• I/we will immediately notify the Administrator in writing in the event there is a change to any of the information provided<br />
in relation to this application.<br />
• I/we declare that I am/we are aged 18 or over.<br />
• I/we acknowledge that no Participating Shares will be issued until applications for Participating Shares totaling £1 million<br />
in aggregate have been received under the First Offer and the Second Offer. If applications for Participating Shares to<br />
this value are not received, the Cell may not proceed and in such case subscription monies received will be returned to<br />
applicants without interest (which will be applied to meet the costs of the Company incurred in relation to the anticipated<br />
fund–raising at that point)<br />
• I/we acknowledge that any application monies representing fractions of £1.00 will be retained by the Cell.<br />
• I/we hereby acknowledge and agree that subscription monies may immediately, on receipt, be paid in or towards underlying<br />
investments including the Fund prior to the issue of Participating Shares and prior to my/our admission as a shareholder.<br />
Until Participating Shares are issued my/our application monies shall rank as an unsecured loan to the Company.<br />
• I/we understand that the value of shares can go down as well as up, and that upon realisation of the investments, the<br />
proceeds received may be less than the amount invested.<br />
• This application form when accepted on behalf of the Company, constitutes an agreement between me/us and<br />
the Company.<br />
• This agreement is to be governed by and interpreted in accordance with Guernsey law.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong>
Email:<br />
DECLARATION CONTINUED<br />
• I understand that any costs incurred by the Company or the Cell as a result of my/our failure to transmit cleared funds by<br />
the latest time provided for in the Cell Particulars shall be borne by myself/us.<br />
• I/we understand that application monies will be held in a client account once the acknowledgement of a completed<br />
application form has been sent to me/us. I/we also understand that any interest arising on application monies will accrue<br />
for the sole benefit of the Cell, rather than me/us as Applicant(s).<br />
• I/we represent and warrant that I/we am/are not, and that I/we am/are not applying for the account or benefit of any person<br />
who is a US Person (as defined in Regulation S under the United States Security Act of 1933, as amended) or a citizen or<br />
resident of the United States and was/were not inside the United States at the time of my/our executing or despatching this<br />
form, and am/are not applying with a view to re-offering, reselling, transferring or delivering any of the Participating Shares<br />
which are subject to this application directly or indirectly to, or for the account or benefit of, a person who is a US person or<br />
US citizen or resident or the United States or a person otherwise prevented by legal or regulatory restrictions from applying<br />
for Participating Shares.<br />
• I/we consent to the processing of personal data given in relation to this application and acknowledge and accept that<br />
the Administrator may in order to fulfil its duties to the Company and comply with regulatory requirements: (i) retain<br />
such personal data for prescribed periods after the redemption of the Participating Shares subscribed for; (ii) transfer<br />
such information to applicable tax authorities including the UK Inland Revenue and the Administrator of Income Tax, the<br />
Directors, Investment Manager, Investment Advisor and legal adviser or any agent of the Company entitled to receive such<br />
information; and (iii) transfer such personal data to any person or entity to which the Administrator has a legal obligation to<br />
disclose such information.<br />
• I/we represent and warrant that I/we am/are not (a) person(s) otherwise prevented by legal or regulatory restrictions from<br />
applying for Participating Shares in the Cell nor acting on or behalf of any such person(s) on a non-discretionary basis.<br />
• I/we represent and warrant that I/we am/are entitled to invest in Participating Shares without violating any laws applicable<br />
to me/us.<br />
PLEASE SIGN bELOw<br />
Signature: Please print name: Date:<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 33
34<br />
SECTION 3<br />
VERIFICATION FOR INDIVIDUALS<br />
Email:<br />
THE ADMINISTRATOR NEEDS TO VERIFY THE IDENTITY AND ELIGIbILITY OF INDIVIDUALS<br />
INVOLVED IN MAKING AN APPLICATION FOR PARTICIPATING SHARES. PLEASE SEND wITH<br />
THE APPLICATION FORM:<br />
EITHER:<br />
A a “Letter of Introduction”, in the form of Section 5 of this Application Form, from an IFA or other regulated person (such as<br />
a solicitor or accountant) who is a member of a regulatory authority in one of the jurisdictions listed on the last page of this<br />
Application Form and is required to comply with anti money laundering regulations in that jurisdiction;<br />
OR:<br />
b 1. a certified copy of the passport or national identity card of the individual, bearing a photo. Copies should be certified as<br />
described on the first page of this Application Form; and<br />
2. a certified copy of a utility bill (no more than three months old) in the name of the individual; and<br />
3. a statement regarding the source of funds being invested in the Cell (e.g. savings, employment income, investment<br />
proceeds); and<br />
4. if the Applicant is an individual, information regarding the Applicant’s expertise, experience and knowledge so as to<br />
give us reasonable assurance that the Applicant is capable of making its own investment decisions and understanding<br />
the risks involved. we should normally be able to make our assessment on the basis of a description of:<br />
(a) your current or most recent occupation,<br />
(b) any university degrees or professional qualifications which you hold,<br />
(c) any current company directorships you hold or have held in the last five years,<br />
(d) any companies in which you hold shares, detailing which ones are listed and which unlisted,<br />
(e) any investments you have made in the last five years that are comparable to the Company (for example EIS, VCT),<br />
and<br />
(f) any investment network or syndicate of business angels in which you have been involved for at least six months prior<br />
to the date you sign the Application Form.<br />
PLEASE USE A SEPARATE SHEET TO PROVIDE THIS OR ANY OTHER INFORMATION wHICH YOU<br />
bELIEVE wOULD ALLOw US TO UNDERTAKE OUR ASSESSMENT.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong>
SECTION 4<br />
PAYMENTS<br />
Email:<br />
FORMS OF PAYMENT<br />
PLEASE EITHER<br />
Enclose a cheque or banker’s draft for the amount shown in Section 1 (for individual applicants) or Section 6 (for applicants<br />
that are trusts, corporations or partnerships) made payable to ”JTC FSG re <strong>Foresight</strong> Inv Client a/c”. Cheques should be<br />
crossed “account payee only”;<br />
Cheques must be honoured on first presentation. A separate cheque must accompany each application. No receipt for your<br />
payment will be issued. The cheque or banker’s draft must be drawn in sterling. A personal cheque drawn by someone other<br />
than the Applicant may be used, in which case the Applicant’s full name and address should be written on the back of the other<br />
person’s cheque and the verification requirements in Section 3 must be met for the other person as well as the Applicant. If you<br />
pay by a building society cheque or banker’s draft, you should write the name, address and date of birth of the Applicant on the<br />
back of the cheque or banker’s draft. If the Applicant is a corporation, trust or partnership, the cheque must be drawn on an<br />
account held in the corporation, trust or partnership’s name.<br />
OR<br />
If you wish to invest by electronic funds transfer, complete the instruction overleaf and send it to your bank. Include a copy of it<br />
when sending the Application Form.<br />
Note: If the Applicant is a corporation, trust or partnership, the payment must be sent from an account held in the corporation,<br />
trust or partnership’s name.<br />
Email:<br />
bANK ACCOUNT DETAILS<br />
Please provide details of the account to which the Company should pay dividends and redemptions by electronic funds transfer.<br />
If no details are given, dividends and redemption proceeds will be sent by cheque.<br />
Account Name: Account No:<br />
Name of bank: Sort Code (UK banks):<br />
IbAN No (Non UK banks): SwIFT No (Non UK banks):<br />
Address of bank:<br />
Telephone:<br />
Post Code:<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 35
36<br />
SECTION 4 PAYMENTS<br />
Email:<br />
FORM OF INSTRUCTION TO YOUR bANK<br />
If you wish to pay by electronic funds transfer, complete this page and send to your bank. Include a copy of the completed page<br />
when returning your Application Form.<br />
Email:<br />
ENTER DETAILS OF THE ACCOUNT FROM wHICH PAYMENT SHOULD bE MADE<br />
To: (Name and address of your bank/building society):<br />
PLEASE SIGN bELOw<br />
Sort code (if UK bank):<br />
Account name: Account no:<br />
ENTER YOUR INVESTMENT AMOUNT bELOw<br />
Please remit the sum of £ net of all charges by electronic funds transfer to the account below<br />
when making the payment, please quote my full name as a reference.<br />
Email:<br />
TICK ONE bOX bELOw<br />
Tick either<br />
q to pay by CHAPS<br />
(only for payments from UK banks/buildings societies)<br />
bank: AbN AMRO (Guernsey) Limited<br />
Sort code: 60–91–65<br />
Account name: JTC FSG re <strong>Foresight</strong> Inv Client a/c<br />
Account no: 10503594<br />
IbAN: Gb67MEES60916550359401<br />
Signature(s): Name of signatory(ies): Date:<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
or<br />
q to pay by SwIFT<br />
bank: AbN AMRO (Guernsey) Limited<br />
SwIFT code: MEESGGSPXXX<br />
Account name: JTC FSG re <strong>Foresight</strong> Inv Client a/c<br />
IbAN: Gb67MEES60916550359401
SECTION 5<br />
LETTER OF INTRODUCTION<br />
Email:<br />
TO bE COMPLETED bY THE APPLICANT’S FINANCIAL ADVISER AND ADDRESSED TO JTC FUND SERVICES<br />
(GUERNSEY) <strong>LIMITED</strong>, LA PLAIDERIE HOUSE, LA PLAIDERIE, ST. PETER PORT, GUERNSEY, GY1 1wF<br />
Firm Name: Contact Name:<br />
Firm Address:<br />
Telephone:<br />
Email:<br />
Regulated entity number or FSA registration no:<br />
Email:<br />
wE CERTIFY THAT<br />
1. we have undertaken an adequate assessment of the Applicant’s expertise, experience and knowledge such<br />
as to give reasonable assurance to <strong>Foresight</strong> and the Administrator in the light of the nature of the transactions<br />
or services envisaged that the Applicant is capable of making its own investment decisions and understanding<br />
the risks involved in subscribing for Participating Shares.<br />
2. we have applied customer due diligence measures on a risk-sensitive basis in respect of the Investor to<br />
the standard required by The Money Laundering Regulations 2007 within the guidance for the UK<br />
Financial Sector issued by the Joint Money Laundering Steering <strong>Group</strong> (see notes below) or by the Criminal<br />
Justice (Proceeds of Crime) (Financial Services businesses) (bailiwick of Guernsey) Regulations and we<br />
certify that:<br />
a. the beneficial owner is the Applicant OR insert details:<br />
b. i. we have identified and verified the identity of the Applicant on the basis of reliable and independent source<br />
documents, data and information;<br />
ii. where there is a beneficial owner who is not the Applicant, we have identified the beneficial owner<br />
and have taken adequate measures, on the basis of reliable and independent source documents, data<br />
and information, to verify the beneficial owner’s identity so that we know who the beneficial owner is,<br />
including, in the case of a legal person, trust or similar arrangement, measures to understand the<br />
ownership and control structure of the person, trust or arrangement and the identity of the beneficial<br />
owner; and<br />
iii. we have obtained information on the Applicant’s occupation and the source of funds to be used for<br />
the Applicant’s proposed subscription for Participating Shares.<br />
PLEASE COMPLETE AND SIGN OVERLEAF<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 37
38<br />
SECTION 5 LETTER OF INTRODUCTION<br />
Email:<br />
wE CERTIFY (CONTINUED)<br />
3. we understand that Administrator has obligations under the Criminal Justice (Proceeds of Crime) (Financial Services<br />
businesses) (bailiwick of Guernsey) Regulations, as set out on page 11 of the Scheme Particulars, and we will cooperate<br />
with the Administrator in the event of a request for copies of the due diligence materials we hold in respect of the<br />
Applicant, and that we will provide the same within 2 business Days of a request. we acknowledge and agree that<br />
such request may cause us to request additional information from the Applicant (see notes below), and that the<br />
Administrator reserves the right to contact the Applicant directly in the event that all information is not provided<br />
within the above timeframe. We confirm that both we and the Applicant are aware of and understand that failure<br />
to provide the information requested may cause the Administrator to take the steps noted on page 11 of the<br />
Scheme Particulars.<br />
4. At any time during the lifetime of the Cell, we will advise the Administrator immediately should our relationship with the<br />
Applicant terminate.<br />
TO bE SIGNED bY ADVISER<br />
Signature: Please print name: Date:<br />
Notes: The Administrator’s obligation under the Criminal Justice (Proceeds of Crime) (Financial Services businesses) (bailiwick of<br />
Guernsey) Regulations extends from the point of a request to subscribe for Participating Shares in respect of an Applicant, through<br />
to the point the Participating Shares are redeemed. It should be noted that one or more requests for due diligence information may<br />
be made at any time during that period.<br />
In the event the Administrator requests information from an Introducer in respect of an Applicant, such request will be made in<br />
accordance with The Criminal Justice (Proceeds of Crime) (Financial Services businesses) (bailiwick of Guernsey) Regulations (and<br />
any amendment thereto). where the information obtained by an Introducer in compliance with The Money Laundering Regulations<br />
2007 within the guidance for the UK Financial Sector issued by the Joint Money Laundering Steering <strong>Group</strong> is insufficient to meet<br />
the needs of the Administrator, the Introducer will be required to obtain the additional information.<br />
COMMISSION wAIVER<br />
Complete both boxes below to indicate how much of the 3% commission should be paid to the adviser and how much<br />
should be rebated to the applicant in the form of Additional Shares<br />
Pay to adviser %<br />
waive for additional shares %<br />
Total 3%<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong>
SECTION 6 COMPLETE THS SECTION IF APPLICANT<br />
IS A TRUST, CORPORATION OR PARTNERSHIP<br />
Email:<br />
APPLICANT IS A CORPORATION<br />
Date of incorporation:<br />
Name of corporation (registered):<br />
Correspondence address:<br />
Post code: Country:<br />
Telephone:<br />
Email:<br />
Email:<br />
APPLICANT IS A TRUST<br />
Date trust established:<br />
Name of trust:<br />
Registered/incorporation no. of trust:<br />
Country in which trust is established/registered:<br />
Names of all trustees :<br />
Correspondence (registered) address:<br />
Post code: Country:<br />
Contact name:<br />
Telephone:<br />
Email:<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 39
40<br />
SECTION 6 COMPLETE THS SECTION IF APPLICANT IS A TRUST, CORPORATION OR PARTNERSHIP<br />
Email:<br />
APPLICANT IS A PARTNERSHIP<br />
Date partnership established:<br />
Name of partnership (registered):<br />
Correspondence (registered) address:<br />
Post code: Country:<br />
Contact name: Telephone:<br />
Fax: Email:<br />
FIRST OFFER - MINIMUM £10,000<br />
Investment amount: £<br />
Please tick here if the applicant is resident in Guernsey for tax purposes q<br />
we wish to invest the above amount in the <strong>Foresight</strong> Environmental Cell of <strong>Foresight</strong> Investments <strong>PCC</strong> Limited on the basis of the<br />
Scheme Particulars and the Cell Particulars under the terms of the First Offer or the Second Offer.<br />
AUTHORISED PERSON 1<br />
Signature: Please print name: Date:<br />
AUTHORISED PERSON 2<br />
Signature: Please print name: Date:<br />
Information such as annual reports of the Cell will be sent by email to the email address shown above. If you prefer to receive paper<br />
copies please tick this box. q<br />
Note:<br />
* The minimum amount under the SECOND OFFER is reduced to £10,000 if the Applicant is:<br />
(a) one of up to 99 persons to whom the Second Offer was specifically made or directed by <strong>Foresight</strong> with a statement to that effect<br />
clearly affixed to the Application Form; or<br />
(b) a Qualified Investor acting on its own behalf or on behalf of a person who has engaged the Qualifying Investor to act as his agent<br />
on terms which enable the Qualified Investor to make decisions concerning the acceptance of offers of transferable securities on<br />
that person’s behalf without reference to that person.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong><br />
SECOND OFFER - MINIMUM £43,500*<br />
Investment amount: £
SECTION 7 VERIFICATION FOR TRUSTS,<br />
CORPORATIONS AND PARTNERSHIPS<br />
Email:<br />
THE ADMINISTRATOR NEEDS TO VERIFY THE IDENTITY AND ELIGIbILITY OF TRUSTS, COMPANIES<br />
AND PARTNERSHIPS MAKING AN APPLICATION FOR PARTICIPATING SHARES. PLEASE SEND wITH<br />
THE APPLICATION FORM:<br />
EITHER<br />
(a) a “Letter of Introduction”, in the form of Section 5 of this Application Form, from an IFA or other regulated person<br />
(such as a solicitor or accountant) who is a member of a regulatory authority in one of the jurisdictions listed on the last<br />
page of this Application Form and is required to comply with anti money laundering regulations in that jurisdiction;<br />
OR<br />
(b) The information listed in the remainder of this section 7.<br />
Email:<br />
IF THE APPLICANT IS A TRUST, PLEASE PROVIDE THE FOLLOwING INFORMATION:<br />
• First page of the trust deed (not the title page), which should show the date the trust was established<br />
• If the trustee is an individual(s), details for each trustee as requested in Section 3 “Verification for Individuals”<br />
• If the trustee is a corporation, jurisdiction in which regulated and regulatory reference number.<br />
• Evidence of legal status of the trust<br />
• Type of trust (discretionary/non discretionary/unit)<br />
• Names of:<br />
(a) Settlor<br />
(b) Current beneficiaries<br />
(c) Protector<br />
• Name of party with power under the trust deed to change the beneficiaries of the trust<br />
• The purpose for which the trust was established<br />
• The source of wealth used to establish the trust, as evidenced by the identification of the payor and the source of proceeds<br />
paid to settle the trust (e.g. savings, employment income, investment proceeds)<br />
• Copy of authorised signatory list<br />
• Details as requested in Section 3 “Verification for Individuals” for each person signing the Application Form (not required<br />
if the trustee is a corporation and the signatory is an employee of the trustee).<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong> 41
42<br />
SECTION 7 VERIFICATION FOR TRUSTS, CORPORATIONS AND PARTNERSHIPS<br />
Email:<br />
IF THE APPLICANT IS A CORPORATION/COMPANY, PLEASE PROVIDE THE FOLLOwING INFORMATION:<br />
FINANCIAL SERVICE bUSINESS REGULATED IN ONE OF THE JURISDICTIONS LISTED ON THE<br />
LAST PAGE OF THIS APPLICATION FORM<br />
• Identification of jurisdiction in which regulated and regulatory reference number.<br />
• Copy of authorised signatory list<br />
• Details as requested in Section 3 “Verification for Individuals” for each person signing the Application Form (not required if<br />
the signatory is an employee of the corporation/company).<br />
A COMPANY QUOTED ON A RECOGNISED STOCK EXCHANGE OR A SUbSIDIARY OF SUCH A COMPANY<br />
• Identification of stock exchange on which company is listed and listing reference number<br />
• Copy of authorised signatory list<br />
• Details as requested in Section 3 “Verification for Individuals” for each person signing the Application Form (not required if<br />
the signatory is an employee of the corporation/company).<br />
ALL OTHER COMPANIES OR OTHER CORPORATE ENTITIES<br />
• Certified copy of the company’s certificate of incorporation, the memorandum & articles of association, or equivalent<br />
constitutive documents<br />
• Certified copy of the passport or national identity card of each company employee authorised to instruct on this account<br />
• Certified copy of share register/unitholders<br />
• Certified list of directors<br />
• Certified authorised signatory list<br />
• The source of funds being invested in the Cell (e.g. savings, employment income, investment proceeds)<br />
• Details as requested in Section 3 “Verification for Individuals” for all signatories who are authorised to instruct on the<br />
account and for any beneficial owners holding more than 25% of the company’s share capital.<br />
Email:<br />
IF THE APPLICANT IS A PARTNERSHIP, PLEASE PROVIDE THE FOLLOwING INFORMATION:<br />
• Certified copy of the partnership agreement<br />
• Certified list of all the partners<br />
• Certified copy authorised signatory list<br />
• The source of funds being invested in the Cell (e.g. savings, employment income, investment proceeds)<br />
• Details as requested in Section 3 “Verification for Individuals” for all partners.<br />
• Details as requested in Section 3 “Verification for Individuals” (at b 1. and 2. only) for all signatories.<br />
<strong>Foresight</strong> <strong>INVESTMENTS</strong> <strong>PCC</strong> <strong>LIMITED</strong>
JURISDICTIONS<br />
THE FOLLOwING COUNTRIES AND<br />
TERRITORIES ARE REGARDED bY THE<br />
GUERNSEY FINANCIAL SERVICES<br />
COMMISSION AS HAVING EQUIVALENT<br />
REGULATIONS TO GUERNSEY FOR ANTI-<br />
MONEY LAUNDERING PURPOSES wHICH<br />
MEANS THAT FINANCIAL SERVICES<br />
bUSINESSES REGULATED IN THESE<br />
JURISDICTIONS MAY bE TREATED FOR<br />
THE PURPOSES OF THIS APPLICATION<br />
FORM AS IF THEY wERE LOCAL<br />
FINANCIAL SERVICES bUSINESSES:<br />
Austria<br />
Australia<br />
belgium<br />
Canada<br />
Denmark<br />
Finland<br />
France<br />
Germany<br />
Gibraltar<br />
Greece<br />
Hong Kong<br />
Iceland<br />
Ireland<br />
Isle of Man<br />
Italy<br />
Japan<br />
Jersey<br />
Luxembourg<br />
Netherlands<br />
New Zealand<br />
Norway<br />
Portugal<br />
Singapore<br />
South Africa<br />
Spain<br />
Sweden<br />
Switzerland<br />
United Kingdom<br />
United States of America
<strong>Foresight</strong> <strong>Group</strong><br />
La Plaiderie House<br />
La Plaiderie<br />
St Peter Port<br />
Guernsey<br />
GY1 1wF<br />
Channel Islands<br />
t: +44 (0) 1481 702400<br />
f: +44 (0) 1481 702407<br />
www.foresightgroup.eu<br />
This publication is printed on paper sourced from certified sustainable forests.<br />
Designed and produced by Fat Media.